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ABSTRACT 
Iron deficiency is the most common global nutritional problem, which can be 
attributed mainly due to poor dietary iron bioavailability. Although many methods exist 
in assessing bioavailability, they may not be applicable for large populations. Algorithms 
have therefore been developed from single meal studies for assessing iron bioavailability. 
However, based on exaggerated effect of dietary factors on iron absorption, new 
algorithms based on complete diet studies are needed.  The objectives of these studies 
were to:  (i) develop a new algorithm from complete diet studies data (manuscript 1); (ii) 
estimate iron absorption from the US diet using the new algorithm (manuscript 2); and 
(iii) investigate the effect of long-term phytate consumption on iron absorption 
(manuscript 3). We developed the algorithm using data from four complete diet studies in 
which nonheme iron absorption was measured in each subject for three different dietary 
periods.  In estimating iron absorption from the US diet, we used the National Health and 
Nutrition Examination Survey (NHANES, 2001-2002), MyPyramid Equivalents 
Database (MPED), and the Food and Nutrient Database for Dietary Studies (FNDDS). In 
the third study, iron absorption from a high phytate test meal was measured using the area 
under the curve (AUC) for serum iron in female subjects with ferritin < 30 µg/L (n=28) 
before and after an eight week dietary modification with high (n=14) or low (n=14) 
phytate diets. In the first study, serum ferritin explained 35 % of the variability in iron 
absorption, whereas the effect of dietary factors was small. In the second study, iron 
bioavailability from the US diet was 15% compared to the currently used value of 18 %. 
The third study found a significant increase in absorption in the high phytate group (640 
to 905 µmol/L; P < 0.05) and a non-significant decrease (337 to 267 µmol/L) in the low 
viii 
 
 
 
phytate group, indicating that the inhibitory effect of phytate on nonheme iron absorption 
is dampened among individuals who consume high phytate diet regularly. The findings of 
these studies have implications for iron nutrition policies for setting recommendations for 
iron intake and biofortification of high phytate staples with iron.  
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CHAPTER 1. GENERAL INTRODUCTION 
Background 
Iron deficiency is the world’s most common nutritional deficiency affecting over 
3.5 billion people in developing countries alone (1). It refers to a state in which iron 
stores are depleted and is mainly caused by either poor dietary iron intake or poor dietary 
iron bioavailability. Iron bioavailability is defined as the fraction of an ingested nutrient 
that is absorbed and subsequently utilized for normal physiological functions (2). Total 
iron bioavailability is a composite estimate made up heme and nonheme iron absorption. 
Heme iron absorption is fairly constant (approximately 25 %) (3, 4), whereas nonheme 
iron absorption is poor and highly variable (5-8). This is mainly because of the influence 
of various dietary factors on nonheme iron absorption. The dietary factors that enhance 
nonheme iron absorption are ascorbic acid and animal tissue. Inhibitors on the other hand 
are mainly polyphenols, calcium salts, and phytic acid (9).  
There are various methods for assessing nonheme iron absorption. In humans it is 
estimated using radio or stable isotopes of iron. Iron absorption in humans could also be 
measured using the area under the curve (AUC) for serum iron (10). In large population 
level studies however, these methods are not feasible due to cost and researcher/subject 
burden. For example, to estimate iron bioavailability from the United States diet, it was 
practically impossible to measure absorption by means of a large population studies. For 
this reason a total iron absorption value of 18 % was estimated using data for 15 subjects 
from a single study (11). Although this was a reasonable approach, it has a limitation of 
small sample size. As means of estimating iron absorption in large population studies 
therefore, several statistical models have been developed which require information on 
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the dietary intakes and or iron status data of subjects. These models have been reviewed 
by Reddy (12). These models were based on data from single meal studies and come with 
the limitation of not accurately estimating iron absorption from complete diets. Single 
meal studies are those in which food labeled with an isotope of iron is fed with a meal 
after an overnight fast. On the contrary, a complete diet study is one in which the main 
meals of the day are labeled over a period of days. When Hunt (13) used the existing 
models to estimate iron absorption from published complete diet data, most algorithms 
either under or overestimated with wide margins. Cook et al. (14) also showed, single 
meal studies exaggerate the inhibiting and enhancing effects of dietary factors on 
nonheme iron absorption compared to complete diet. One of the possible explanations of 
the discrepancy between the single meal and complete diet studies is that with regular 
consumption, individuals may adapt to the effect of dietary factors on iron absorption 
leading to a dampening of the inhibitory/enhancing effects of dietary factors (8). It is 
therefore imperative that a statistical model that is meant to predict iron absorption from 
complete diets should be developed from complete diet data. This research was therefore 
conducted to develop a new algorithm using complete diet data as well as to investigate 
the concept of adaptation in iron absorption. 
Objectives 
1. To develop a new algorithm for predicting nonheme iron absorption using data 
from published complete diet studies. 
2. To estimate iron bioavailability from the US diet using the complete diet based 
algorithm. 
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3. To determine the effect of long term phytate consumption on nonheme iron 
absorption. 
Thesis Organization 
This thesis is organized into six chapters, namely a general introduction (Chapter 
1), literature review (Chapter 2), three research manuscripts (Chapters 3, 4 and 5), and a 
general conclusion (chapter 6). The general introduction comprises of background 
information linking the three different research studies. The literature review is a 
comprehensive review on iron bioavailability. The three manuscripts have been prepared 
according to the Journal of Nutrition format. One of the manuscripts (Chapter 3) has 
already been published, one has been submitted to the Journal of Nutrition (Chapter 5) 
and one (Chapter 4) is yet to be submitted. Tables and figures in each chapter are placed 
at the end of the chapter. All references are cited according to the Journal of Nutrition 
format. For each chapter, the references have been placed at the end of the chapter. 
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CHAPTER 2. LITERATURE REVIEW 
Iron is an indispensable micronutrient in humans. It is required for several 
physiological function including, hemoglobin synthesis, DNA and RNA synthesis, 
cellular respiration, cell proliferation and regulation of post-transcriptional gene 
expression for different proteins (1). The biochemical significance of iron is tied to its 
ability to exist in two different oxidation states (Ferous (II) and Ferric (III), which makes 
it able to both accept and donate electrons. The adult human has 3-5 g iron in the body 
(2), with men having slightly higher (approximately 50 mg/kg) iron content than women 
(approximately 40 mg/kg) due to the smaller red cells, muscles and liver mass in women 
(3). Approximately 10 % of the iron in the body is found in myoglobin and iron 
containing enzymes, and 20-30 % is stored as ferritin and hemosiderin while the 
remaining 60 to 70 % is found in red blood cells as part of hemoglobin (1). A very small 
amount of iron is lost from the body owing to the lack of a structured excretory system 
for iron. This is in the order of 1-2 mg daily and is compensated for by dietary iron 
absorption. This minimal iron loss occurs through various routes including sweating, skin 
desquamation, urinary excretion and sometimes bleeding (4). Most iron loss occurs 
through the gastrointestinal tract (5).   
Iron metabolism in the body including iron absorption, transport and storage is 
tightly regulated. This is essential because excess free iron in the body can lead to free 
radical generation through the Fenton reaction which damages lipid membranes, proteins 
and nucleic acids and is implicated in many chronic diseases including neurological 
diseases (6). Also, the deficiency of iron leads to impaired function of the various iron-
requiring enzymes and systems, with consequences such as fatigue, poor cognition and 
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low productivity. This review addresses current knowledge on essential concepts in iron 
metabolism including absorption, transport, storage, utilization and recycling. It also 
discusses iron bioavailability and iron nutritional status assessment. Sections of this 
review are also given to assessment of the iron nutritional status in populations including 
biochemical indicators as well as statistical methods, particularly the probability 
approach for assessing adequacy of iron intake in populations. 
Iron Absorption 
  Dietary iron comes in the form of heme and nonheme iron. Heme iron is 
exclusively from animal sources, mainly from the breakdown of hemoglobin and 
myoglobin (7). Approximately 40 % of iron from animal sources is heme iron (8). 
Nonheme iron on the other hand is from both plant and animal sources. It is estimated 
that 85-90 % of iron intake in the United States is nonheme (9, 10). In developing 
countries, dietary iron is essentially nonheme with limited heme iron intake. For example, 
among Moroccan children 6 to 10 years old, Zimmermann et al. (11) estimated that 
nonheme iron contributed 97 % of total iron intake. Although nonheme iron constitutes 
the larger proportion of dietary iron intake, it is less bioavailable than heme iron. 
Approximately 25 % of heme iron is absorbed, whereas the absorption of nonheme iron 
can range from <1 % to over 20 % (12). Heme and nonheme iron are absorbed through 
different pathways, with absorption mostly occurring in the duodenum. Iron from 
nonheme sources is in the ferric form and must be converted into ferrous iron before 
absorption. This is facilitated by the ferric reductase duodenal cytochrome b (DCYTB) 
(6). Iron enters the enterocytes through the apical membrane. The uptake of nonheme 
iron is mediated by divalent metal transporter I (DMT1) also known as divalent cation 
7 
 
 
 
transporter I (DCT1). Heme iron on the other hand is in the ferrous form. It is transported 
across the apical membrane by a mechanism that is still not well known. It was suggested 
to be transported by heme carrier protein (HCP1), however, HCP1 has been shown to 
transport mainly folate (13). Heme enters the enterocyte as intact iron protoporphyrin 
complex (4). Inside the enterocyte, the iron is released from heme by the hemeoxygenase 
1 (HO-1).  
Once inside the enterocytes, both sources of iron enter a common labile iron pool 
(7). The iron is either stored as ferritin or exported out of the enterocyte by ferrotportin 
(FPN1) (1, 4). Most of the excess iron that is stored as ferritin is lost through exfoliation 
of the cell. Only about 10 % of the iron stored in ferritin is later exported out of the 
enterocyte (14). FPN1 is expressed in the basolateral membrane of the enterocytes and in 
macrophages, liver, placenta and spleen (1). Surface expression of FPN1 is controlled by 
hepcidin, a peptide hormone which also regulates its function by triggering its 
internalization and degradation in response to iron replete conditions (4). Iron exported 
by FPN1 is taken up by the transport protein transferrin. Due to ferroxidase activity, the 
ferrous iron exported by FPN1 is converted to ferric iron and transported by transferrin. 
In the enterocytes, the ferroxidase activity is provided by hephaestin, a homologue of 
ceruloplasmin. In non-intestinal cells, the ferroxidase activity is provided by 
ceruloplasmin. The expression of the mRNA for DCYTB, DMT1, HO-1 and FPN1 is 
regulated by hypoxia inducible factor 2 (HIF-2), while posttranscriptional regulation of 
DMT1 and FPN1 is by iron regulatory proteins (IRPs) in response to intracellular iron 
levels (4, 15).  
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Iron Transport and Cellular Uptake 
The ferric iron is taken up by transferrin and transported to target cells. 
Transferrin is an 80kDa glycoprotein, synthesized mainly by the liver, that has two 
domains for binding iron molecules (2). It is synthesized mainly by the liver and binds 
iron with very high affinity at pH of 7.4 (2, 16).  The holotransferrin is taken up into the 
cell by transferrin receptor (TfR), a transmembrane protein consisting of two identical 
subunits each with a molecular weight of approximately 90-95kDa. Each of the two 
subunits of the TfR binds to one transferrin molecule. There are two types of TfR, 
namely TfR1 and TfR2. TfR1 is expressed in all tissues and is synthesized in the 
endoplasmic reticulum, while TfR2 is expressed only in hepatocytes, duodenal crypt cells 
and erythroid cells (2, 6).  At the target cell surface, TfR1 binds to the holotransferrin and 
the complex is internalized through endocytosis. The release of the iron is mediated by 
acidification of the endosome by ATPase proton pump. The iron is released at a pH of 
~5.5. DMT1 transports the iron across the membrane of the endosome into the cytoplasm 
(17). It is then stored as ferritin or utilized. The apo-transferrin-TfR1 complex returns to 
the cell surface to be able to bind new transferrin. TfR2 binds to transferrin with a lower 
affinity than TfR1and a mutation in its gene has been linked to hemochromatosis (6, 18).  
Iron Storage 
The body stores 0-15 mg/kg of iron mainly as ferritin with a small proportion as 
hemosiderin. Over one half of the body’s ferritin is found in the liver, whereas the 
remaining is mainly found in muscles and in the reticuloendothelial system. Ferritin is 
composed of 24 subunits and a cavity capable of storing over 4,000 iron atoms in the 
ferric form (18, 19). Mammalian ferritin comes in two different subunits, namely the 
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heavy (H) and the light (L) chain subunits. The H-ferritin is a 22 kDa protein whereas the 
L-ferritin is a 20 kDa protein. The two isoforms contain 182 and 174 amino acids 
respectively. Ferritin is approximately 20 % saturated in vivo which implies that 
approximately 800 iron (Fe III) sites are filled (5). The proportion of the two subunits is 
dependent on the type of tissue (6). Ferritin with high level of the H subunit is mostly 
found in the heart and brain, and has high ferroxidase activity, whereas, the L dominating 
ferritin is found predominantly in the liver and spleen with more iron storage capacity in 
their cavity, and facilitates iron nucleation and turnover of the ferroxidase center (19, 20). 
Ferritin first reacts with ferrous iron, oxidizing it to ferric iron for deposition into its 
cavity. It uses dioxygen as an oxidant in the reaction that occurs at the ferroxidation 
center. Since this reaction uses both ferrous iron and oxygen, it is considered inhibitory to 
the formation of free radicals. Thus apart from iron storage, ferritin also deprives the 
fenton reaction of important substrates. Iron stored in ferritin is released when needed by 
the body, mainly through proteolytic ferritin degradation. Alternatively, in disease 
conditions, ferric iron in ferritin may be reduced to ferrous iron resulting in the release of 
the iron (19). Most of the stored iron in the liver is stored as ferritin, with approximately 
5 % stored as hemosiderin. Hemosiderin, found mainly in kupfer cells lysosomal 
remnant, is a byproduct of lysosomal degradation of ferritin, particularly H-rich ferritin. 
It is reported that in iron overload, there is increased accumulation of both hemosiderin 
and ferritin irrespective of the cause of the iron overload. However, the rate of 
accumulation of hemosiderin is higher (about 10 times that for ferritin) (5, 21). This may 
be due to that fact that ferritin is damaged during iron overload by increased oxidation 
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reduction reactions, leading to the formation of more hemosiderin (or damaged ferritin) 
(22). 
Regulation of Iron Storage and Uptake 
Ferritin and transferrin receptor  
Regulation of iron storage and uptake occurs mainly at the post-
transcription/translation level. This is accomplished through the iron responsive elements 
(IRE) and IRPs. There are two types of IRPs, namely IRP1 and IRP2. Both types of IRP 
are expressed in all tissues, however, IRP2 is expressed in lesser quantities in most 
tissues. The function of this protein depends on the intracellular iron concentration. The 
IREs are located either at the 3’ untranslated region (UTR) or the 5’UTR of the mRNA. 
They may act as either repressors/inhibitors or enhancers of translation under different 
condition. For proteins with IRE on the 3’UTR, the binding of the IRP to the IRE leads to 
the stability of the mRNA resulting in translation and increased synthesis of the protein. 
On the other hand when the IRE is located at the 5’UTR, the binding of the IRPs to the 
IRE blocks translation of the mRNA (20). While the IRE for ferritin is located at the 
5’UTR that for TfR is located at the 3’ UTR. In iron deficiency, the IRP binds to the IRE 
for both ferritin and TfR. In the case of ferritin, this results in the blocking of translation 
and thus prevents ferritin synthesis. On the other hand, there is increased stability of the 
TfR mRNA, resulting in translation and increased protein synthesis. On the contrary, in 
iron replete situation IRP does not bind to the IRE, there is increased translation of the 
ferritin mRNA and increased ferritin synthesis for iron storage. TfR mRNA on the other 
hand is rendered unstable, affecting the translation and synthesis of the protein.  Iron 
regulates the function of IRP1, which is also capable of functioning as an isoform of 
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cytoplasmic aconitase. In iron replete conditions, there is the assembly of [4Fe-4S] 
clusters which reduces the affinity of IRP1 for the IRE. In iron deficiency conditions 
however, there is a disassembly of the [4Fe-4S] cluster. Thus IRP1 has a strong affinity 
for the IRE. It therefore binds IRE, functioning as a DNA binding protein.  IRP2 unlike 
IRP 1 does not have [4Fe-4S] clusters. Its regulation by iron occurs through degradation 
by proteasomes (23).  
Apart from its role in the storage of iron and the prevention of free radical 
formation, ferritin is a major predictor of iron absorption from meals.  It has been 
reported that ferritin accounts for at least 60 % of variability in iron absorption (from 
nonheme sources) affecting absorption by 10-15 folds (24). Other authors have suggested 
a more moderate influence of ferritin on nonhene iron absorption. According to Armah et 
al. (25) ferritin explains 35 % of variability in nonheme iron absorption from whole diets 
and Reddy et al. (26) reported that ferritin accounted for 32 % of variability in nonheme 
iron absorption. Ferritin is inversely related to iron absorption. As iron stores increases, 
the absorption of nonheme iron decreases and vice versa (27). 
The role of hepcidin in iron metabolism 
Hepcidin is an antimicrobial hormonal peptide, considered as the main regulator 
of iron absorption. It is important in iron homeostasis playing a key role in iron 
absorption, recycling and mobilization (28). Hepcidin is composed of 25-amino acids, 
and is mainly produced by the liver. The liver hepatocytes produce preprohepcidin, the 
precursor form. This is encoded by the hepcidin antimicrobial peptide (HAMP) gene. The 
preprohepcidin consists of 84 amino acids, and is converted into the 25 amino acid 
hepcidin through enzymatic cleavages. Apart from hepcidin 25, other isoforms of 
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hepcidin (22 and 20 carboxyterminal amino acid forms) are also produced, however these 
have little or no biological activity (28, 29). 
HAMP gene transcription is induced by various factors including body iron 
stores, erythropoiesis, oxidative stress, hypoxia and inflammation (29, 30). High body 
iron stores and inflammation increase hepcidin concentration whereas hypoxia and 
erythropoiesis downregulate hepcidin production. Among the different factors, body iron 
store is the main inducer of hepcidin expression. The activation of the HAMP gene by 
iron status is effected through the bone morphogenic proteins (BMP) and their receptors 
at the plasma membrane of hepatocytes. Repulsive guidance molecules (RGM) control 
the downstream effect of the BMP. An example of RGM is hemojuvelin (HJV) which 
provides specificity to the iron signal in the liver. Other proteins that play important role 
in the induction of hepcidin expression by iron are HFE and TfR 2. The functional loss of 
these proteins is associated with reduced hepcidin expression (29). Hypoxia, on the other 
hand is suggested to decrease hepcidin production by stimulating erythropoietin (EPO) 
synthesis. The body responds to hypoxia by increasing red blood cells production, a 
process mediated by hypoxia inducible factors (HIFs) which stimulate EPO production in 
the liver and kidney, leading to erythropoiesis. Studies have shown that HIF1 suppresses 
the HAMP gene through this process (31, 32). Due to increased erythropoiesis, there is 
increased iron requirement, resulting in decreased hepcidin levels and increased iron 
absorption (4). During infection or inflammation, hepcidin concentration is increased. 
Hepcidin is an acute-phase protein and the increased production of hepcidin is mediated 
by lipopolysaccharides (LPS) and cytokines mainly interleukin- 6 (IL-6) (4, 33). LPS on 
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the other hand may mediate hepcidin production by inducing endoplasmic reticulum 
stress and activating C-AMP responsive element binding protein H (CREBH) (29, 34). 
Hepcidin regulates iron homeostasis through its regulation of FPN1 expression 
and function (28). Hepcidin binds to FPN1 to reduce iron export. FPN1, a multi-domain 
transmembrane protein, is the main exporter of iron from the enterocyte, hepatocytes and 
macrophages. It is encoded by the solute carrier family 40 member 1 (SLC40A1) gene 
and expressed by duodenal enterocytes, hepatocytes, reticuloendothelial macrophages as 
well as placental syncytriotrophoblast. The binding of hepcidin to ferroportin leads to 
ferroportin being internalized, dephosphorylated and degraded (29). This results in lower 
iron absorption and impaired release of iron from macrophages.  
Hepcidin is implicated in anemia of inflammation and chronic disease, and in 
hemochromatosis, two virtually opposite conditions, due to its role in regulating iron 
homeostasis. Anemia of chronic disease, which is linked to overexpression of hepcidin, is 
characterized by decreased iron absorption in the intestines and macrophage iron release, 
and an increase in reticuloendothelial iron. The stimulation of hepcidin production in 
inflammation is attributed to the cytokine IL-6 (35, 36).  
On the other hand, hemochromatosis which is mainly caused by insufficient 
production of hepcidin by the hepatocytes is characterized by inappropriately low levels 
of hepcidin and hyperabsorption of dietary iron which leads to tissue iron accumulation 
and consequent iron mediated organ dysfunction (37, 38). In a study to investigate the 
relationship between hepcidin and different conditions of iron overload, Papanikolaou et 
al. (39) measured hepcidin levels among 21 subjects with hemochromatosis caused by 
different conditions. They found that patients with thalassemia had very low urinary 
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hepcidin values, with some having no detectable values. Among subjects with congenital 
dyserythropoietic anemia type 1 (CDAI) and those with Juvenile hemochromatosis 
hepcidin levels were also undetectable.    
Iron Utilization and Recycling 
Most intracellular iron metabolism occurs in the mitochondria. However, there is 
limited data on the mechanism of iron transport from the endosome after cellular uptake 
to the mitochondria. Mitochondria is the site for the synthesis of Fe-S clusters and heme 
(40). The synthesized heme is incorporated into hemoglobin and other hemoproteins. Fe-
S clusters are protein cofactors found in the mitochondria, nucleus and cytosol that take 
part in catalytic and regulatory processes in electron transport, tricarboxylic acid (TCA) 
cycle, amino acid biosynthesis and DNA replication and repair and the regulation of gene 
expression (41). Fe-S cluster are also critical in the regulation of iron homeostasis 
through the regulatory binding protein IRP1, which with the acquisition of a 4Fe-4S 
cluster functions as (c-) aconitase under iron replete conditions (42). The synthesis of 
heme occurs mainly in developing red blood cells in the marrow with a small fraction 
(~15 %) occurring in the liver. The biosynthesis of heme occurs in the following four 
steps: [1] formation of the pyrrole, [2] assembly of the tetrapyrole, [3] modification of the 
tetrapyrole sidechains, and [4] the formation of protoporphyrin IX and insertion of iron 
(3). The insertion of iron into protoporphyrin IX is catalyzed by ferrochelatase. The Fe-S 
clusters produced in the mitochondria are linked to the synthesis of heme through its 
effect on the translation of the mRNA for delta-aminolevulinate synthase 2 (ALAS2) one 
of two enzymes that catalyze the formation of the pyrrole in heme biosynthesis (3). In the 
translation of the ALAS2 mRNA, the binding of IRP to IRE at the 5’ UTR blocks 
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translation. However, the addition of an Fe-S cluster reduces the affinity of the IRP for 
IRE inhibiting the binding and enhancing the translation process (3). 
Iron recycling is a primary function of macrophages which are commonly found 
in bone marrow and spleen. They catabolize heme from senescent and damaged 
erythrocytes releasing the iron using heme oxygenase after phagocytosis. Macrophages 
recover the iron for the synthesis of hemoglobin and for incorporation into iron requiring 
enzymes. Iron recycling contributes significantly to daily iron needs. About 20 mg of iron 
is needed for de novo hemoglobin synthesis every day, which is mainly obtained from 
recycled iron (4). The recycling process contributes over 10 -20 times the iron flux from 
intestinal iron absorption (20, 43).  
Functions of Iron 
DNA synthesis 
The role of iron in DNA synthesis and repair is tied to its role in the activity of the 
enzyme ribonucleotide reductase (RNR). RNR catalyzes the rate limiting step in the de 
novo synthesis of deoxyribonucleotide triphosphates (dNTP) (44). They reduce 
ribonucleotides to dNTP. The RNR enzyme is composed two subunits, R1 and R2. The 
R1 subunit contains the catalytic site for the binding and reduction of ribonucleotides to 
dNTPs, and two sites for allosteric binding, and is located in the cytosol. The R2 subunit 
on the other hand is located in the nucleus and contains a tyrosyl group which requires 
iron for its stability. While the R1subunit is expressed at all stages of the cell cycle, the 
R2 subunit synthesis is only initiated at the S-phase for DNA synthesis. Impaired iron 
supply to the R2 inactivates R1 leading to impaired dNTP synthesis with implication on 
DNA synthesis and repairs (45, 46).  
16 
 
 
 
Iron and energy metabolism 
The enzyme aconitase is involved in the interconversion of citrate and isocitrate 
through a cis-aconitase intermediate as seen in the citric acid cycle and glyoxylate cycle. 
There are two types of aconitase, which are coded by different genes. These are the 
cytoplasmic (c-) aconitase and the mitochondrial (m-) aconitase. The iron regulatory 
protein, IRP1 is bifunctional, acting as a DNA binding protein in iron deficiency and as a 
(c-) aconitase in iron replete situations. The role of IRP1 depends on the presence or 
absence of an [4Fe-4S] cluster. In iron replete conditions, there is assembly of [4Fe-4S] 
clusters in IRP1 which decreases its affinity for the IRE turning it into (c-) aconitase. In 
iron depleted conditions, the [4Fe-4S] cluster is dissembled, and IRP1 acts as a binding 
protein (44). The enzymatic activity of (m-) aconitase, which catalyzes the 
interconversion of citrate and isocitrate in the citric acid cycle, is affected by iron levels. 
Like the (c-) aconitase, it also contains a [4Fe-4S] cluster, and its function is regulated by 
the assembly and disassembly of the [4Fe-4S] cluster (47) 
Oxygen and electron transport  
Iron is critical in the transport of oxygen as well as in the respiratory chain. Many 
of its functions are related to its importance in heme biosynthesis. Heme is composed of a 
ferrous iron inserted in the center of a protoporphyrin ring that consists of four pyrrole 
rings. It is a key component of hemoglobin which is required for the transport of oxygen 
and carbon dioxide in the cardiovascular system. Hemoglobin, a tetrametric protein 
composed of four polypeptide chains (2 alpha and 2 beta globin chains), is mainly found 
in erythrocytes. It carries oxygen from the lungs to the body tissues and carbon dioxide 
from the tissues to the lungs. Apart from being a component of hemoglobin, heme is also 
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a cofactor for many enzyme including catalases and peroxidases. It is also a component 
of cytochromes, electron transport proteins found mostly in the mitochondria that play 
important roles related to energy metabolism (48). Apart from cytochromes, the role of 
iron extends to its function as part of Fe-S clusters. Fe-S clusters also play important roles 
in the respiratory chain. Fe-S clusters like the cytochromes are involved in electron 
transport. They also play several other biological roles including substrate binding and 
activation, regulation of gene expression, regulation of enzyme activity, and disulphide 
reduction (49). 
Iron Deficiency and Anemia 
Iron status refers to a continuum of body iron levels ranging from iron deficiency 
anemia to iron overload. Iron deficiency essentially refers to the lack of mobilizable iron 
stores due to depletion of body iron stores. The body iron homeostasis is tightly 
regulated. With no system in place for excreting iron from the body, body iron needs are 
mostly met by recycling iron. The very little iron (1-2 mg) that is lost daily is replaced by 
absorbed dietary iron. Typically iron from stores or from the intestines after absorption is 
transported to target cells by transferrin. When iron supply from these sources are 
diminished, there is a decrease  in iron available for transport by transferrin as well as 
transferrin saturation, and a concomitant increase in TfR as compensatory mechanism to 
take up as much iron as possible  (50, 51). With time, iron deficiency affects 
erythropoiesis resulting in a decrease in hemoglobin levels. While iron deficiency 
contributes a huge proportion of anemia cases, anemia is also caused by other factors. It 
is estimated that up to 50 % of anemia cases are due to iron deficiency while other causes 
include intestinal parasites, malaria, and deficiency in other nutrients (vitamin B12, 
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folate, etc.) as well as congenital issues  (51, 52). Anemia is a highly prevalent public 
health concern around the globe. It affects over 1.6 billion people the world over and 
mostly common in developing countries (52). It is estimated that some 46 % of people in 
Africa and 56 % of South-East Asians are anemic (53). Most affected groups are women 
of child bearing age (due to menstrual losses), and infant, young children and pregnant 
women (as a result of their increased iron requirements) (54). Iron deficiency is mostly 
attributed to poor iron absorption, low dietary iron intake, increased iron requirement and 
increased iron loses (8). Particularly in developing countries, poor iron absorption is 
considered one of the key causes of iron deficiency. In these countries, dietary iron is 
mainly from nonheme sources which are not well absorbed. The diets in these countries 
are also high in phytic acid which is a known inhibitor of iron absorption. Another 
component of the meal that may inhibit nonheme iron absorption in developing countries 
is polyphenol which occur in high levels in some legume varieties such as beans 
consumed frequently in developing countries as well as tea and coffee.  
Consequences of Iron Deficiency 
The consequences of iron deficiency anemia are grave including adverse 
pregnancy outcomes, poor cognitive development, reduced working capacity and 
productivity, and impaired endocrine and neurotransmitter function. It is also associated 
with decreased resistance to infections, increased heavy metal absorption, and increased 
infant mortality (55). The following sections discuss some of the consequences of iron 
deficiency. 
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Adverse pregnancy outcome 
Pregnant women are the most vulnerable groups for iron deficiency and anemia, 
especially during the last trimester. This happens because most iron transfer to fetus 
occurs after 30 weeks of gestation.  Pregnancy is associated with marked changes in 
hematological parameters. For instance, there is an increase in plasma volume and a 
consequent decrease in hemoglobin concentration. Also ferritin levels decrease markedly 
between weeks 12 and 25 (56). Similarly, iron requirement are increased during 
pregnancy. At the early stages, there is about a 2.5 fold increase in requirement, which 
later on increases to about 6.5 fold during the third trimester. However, this is 
accompanied by a concomitant increase in nonheme iron absorption to up to 66 % at 36 
weeks of gestation (57).  The pregnant mother with poor dietary iron intake becomes 
prone to iron deficiency particularly in the third trimester because the fetus will rely on 
the mother’s iron stores. One of the key factors relevant for a positive pregnancy outcome 
is adequate plasma volume expansion. Impairment in plasma volume expansion may 
result in high blood viscosity, high pressure of blood flow, and placental abruption. There 
is also increased risk of preeclampsia and intrauterine growth restriction with high 
hemoglobin concentrations in pregnancy (57). In a study to probe the relationship 
between maternal hemoglobin concentration during labor and neonatal birth Sekhavat et 
al. (58) found a significantly increased risk of low birth weight among women with 
hemoglobin concentrations less than 10 g/dL. Although they observed an increased risk 
among women with hemoglobin concentrations above 13 g/dl this was not statistically 
significant.  In another study, the relationship between maternal hematological status and 
risk of low birth weight was investigated among 1,400 Nepalese women in a case-control 
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study (59). The authors found that low hematocrit values at first and last trimesters were 
associated with lowest mean birth weight. They reported that women with severe anemia 
(Hematocrit < 24 %) had significantly higher risk of low birth weight infant and preterm 
infant delivery compared to those with hematocrit in the reference range (34-36 %).  
While one out of every three women in the severely anemic group had a preterm delivery, 
only 5 % of those in the reference range group had preterm delivery. In another case-
control study to investigate the risk factors for low birth weight and preterm births in 
Ahmedabad, India, Mavalankar et al. (60) found clinical anemia as a significant 
independent risk factor.   In yet another study, Levy et al. (61) found maternal anemia as 
a risk factor for both low birth weight and preterm delivery. 
Poor cognitive development and impaired neurotransmitter function 
Iron deficiency is the most prevalent nutrient deficiency between 6-24 months of 
age. This is the period of maximal brain growth, and unfolding of many 
neurodevelopmental processes. At birth the brain has reached <30 % of the adult size and 
continues to grow up to 2 years of age. Since most brain growth occurs at this time, 
adequate iron in the diet is critical at this stage. The effect of iron deficiency at this stage 
can only be partially corrected in later life (62). Many studies have shown a relationship 
between iron deficiency/anemia and poor cognition among children. In a longitudinal 
study Lozoff et al. (63) followed up with Costa Rican children who had been tested and 
treated for iron deficiency when they were infants. They found that children (ages 11-14 
years) who had severe iron deficiency during infancy were prone to poorer motor and 
mental functioning compared to their normal counterparts. In another study that 
investigated the effect of iron deficiency anemia on specific domains of cognitive 
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function in infancy, Carter et al. (64)  assessed five different aspects of cognitive 
processing. They found that iron deficiency anemia affected two of the five aspects of 
cognition, namely object permanence and recognition memory. 
  A possible explanation for the effect of iron deficiency on cognition is the 
involvement of iron in the hippocampal formation and neurotransmitter function 
especially in the dopaminergic system. Another speculated mechanism is related to the 
fact that iron levels are particularly high in the basal ganglia and the cerebellum that are 
important in motor function, as well as the role of iron in myelin formation and 
maintenance (63). The peak period for iron uptake into the brain occurs at the time of 
myelin synthesis. Overall explanations to the effect of iron deficiency on cognition may 
be due to either low brain oxygen acquisition or that it leads to low brain iron which 
results in low neurotransmitter levels, impaired transmission, impaired myelin formation 
and poor neuromaturation (62, 65, 66). 
Reduced work capacity and productivity 
 Reduced work tolerance and poor working capacity are very common symptoms 
of anemia. Gardner et al. (67) investigated the relationship between hemoglobin 
concentration and work capacity and found that work tolerance is lower among anemic 
subjects compared to subjects with normal hemoglobin concentrations. Edgerton et al. 
(68) also found a strong positive correlation between hemoglobin concentration and work 
tolerance among adult subjects. Their work suggested that hemoglobin changes rather 
than other changes in iron status may largely explain the reduced work capacity in 
anemia. Among subjects with iron deficiency anemia, Ohira et al. (69) found increased 
maximal work time after treatment with iron dextran, whereas no changes were found in 
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the placebo group. The relationship between anemia and work capacity may be due to the 
role of iron in energy production. Iron is involved in the transport of oxygen, in the 
respiratory chain, and is a component of several enzymes.  As a component of red blood 
cells, iron-containing hemoglobin is critical in the transport of oxygen from the lungs to 
the body tissues. Myoglobin, another iron containing protein in the cytoplasm of muscle 
cells, is involved in the diffusion of oxygen towards the mitochondria. Cytochromes 
involved in electron transfer chain in mitochondria and enzymes such as dehydrogenases 
involved in substrate oxidation all require iron (70).   
Assessment of Iron Nutritional Status 
Accurate methods for the assessment of iron nutritional status are critical 
considering the global magnitude of the problem of iron deficiency. The World Health 
Organization (WHO) (51) recommends that clinical and population level screening for 
iron deficiency anemia should be based on the resourcefulness of the country in which 
the assessment is being made. In developed countries, iron status screening at the clinical 
level should be based on hemoglobin and hematocrit together with serum ferritin and 
transferrin saturation while diagnosis or confirmation should include other biomarkers 
such as erythrocyte protoporphyrin, TfR, mean cell volume and response to iron 
administration. In poorly resourced countries on the other hand clinical examinations 
(significant pallor of eyelids, palm, nail beds and tongue) should be used in screening to 
identify high risk individuals while hemoglobin or hematocrit with iron administration is 
used for diagnostics or confirmation of anemia in individuals. The complexity in the 
assessment of iron status lies in the fact that each of the different biomarkers has its own 
limitations. Ferritin is one of the commonly used measures of iron stores. Among 
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children under 5 years of age, a ferritin concentration less than 12 µg/L is indicative of 
depletion in iron stores, while the cut off for older individuals is less than 15 µg/L. 
However, apart from the fact that ferritin level differ between males and females (higher 
in males) ferritin is increased during infection because it is an acute phase protein which 
may be due to the fact that inflammation inhibits iron release from reticuloendothelial 
stores (71). Thus, ferritin is only a reliable marker of iron stores in populations free of 
infection and inflammation. Unlike ferritin, TfR levels increase in iron deficiency. This 
biomarker is also less affected by inflammation and infection and it does not vary by 
gender, pregnancy status or age, however it is elevated when erythroid activity increases 
(red blood cell synthesis and turnover). Other iron status biomarkers such as tranfserrin 
saturation, and total iron binding capacity (TIBC) are equally limited in their usefulness 
in assessing iron status.  In iron deficiency serum iron and transferrin saturation decreases 
while the TIBC increases. Transferrin saturation and serum iron are affected by diurnal 
variations (51). A combination of multiple biomarkers is thus commonly used in 
assessing iron status. For example, in assessing iron deficiency in the US population, 
Cogswell et al. (72) used two different models, one being the ferritin model which 
classifies individuals as iron deficient if they had abnormal values in any two of three 
parameters (serum ferritin, transferrin saturation and erythrocyte protoporphyrin). The 
ferritin model was also used by Looker et al. (73) in estimating iron deficiency in the US 
population. The most recommended combination being hemoglobin (functional iron), 
TfR (tissue need for iron) and ferritin or bone marrow iron (iron stores) (51).  
A relatively new marker for iron status is hemoglobin content of reticulocytes 
(CHr). This measure indicates how much iron was available to be used in red blood cell 
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synthesis within the past few days.  There are, however, no final cut off values suggested 
for CHr yet (71). Another biomarker that is useful in assessing iron status is the 
TfR/ferritin ratio. This marker measures iron deficiency without anemia a stage of iron 
deficiency also referred to as iron deficiency erythropoiesis. In assessing the usefulness 
of the different biomarkers in assessing tissue iron deficiency, Skikne et al. (74) reported 
that ferritin was the most sensitive marker when there are residual iron stores, whereas 
the TfR is better in functional iron deficiency. In addition, the ratio of the TfR to serum 
ferritin provides a marker useful in assessing iron status over a wide range including 
states of ample iron stores to functional iron deficiency.  
Strategies to Address Iron Deficiency Anemia 
Supplementation 
Supplementation is the fastest way to address nutrient deficiency in populations. 
Several studies have investigated the benefits of iron supplementation in improving iron 
status and mitigating the adverse consequences of iron deficiency and anemia. Menendez 
et al. (75) reported lower incidence of severe anemia associated with iron 
supplementation among infants born in a malaria hyperendemic hospital in Tanzania. 
Among pregnant women in Niger, Preziosi et al. (76) found a significant decrease in 
anemia and iron deficiency in the iron supplementation group during the last trimester. 
Other studies have also reported reduced risk of behavioral problems in children, reduced 
incidience of low birth weight (LBW) infants, higher birth weight, as well as prevention 
of iron deficiency anemia among pregnant women due to iron supplementation (77-79).  
The WHO strongly recommends intermittent (weekly) iron supplementation for 
preschool and school aged children in setting with <20 % prevalence of anemia among 
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these age groups. The recommended doses are 25 mg elemental iron for preschool 
children 24-59 months and 45 mg for school age children (5-12years) (80). Among 
pregnant women, it is recommended that they receive 60 mg iron supplementation daily 
for 6 months and among those living in areas with iron deficiency anemia prevalence > 
40 %, iron supplementation is recommended to continue to 3 months postpartum. This is 
to be taken together with 400 µg folic acid/day (81). Sources of elemental iron for iron 
supplementation include ferrous sulfate, ferrous fumarate or ferrous gluconate (80). 
Recently, there have been concerns about the safety of iron supplementation in 
malaria endemic areas.  Among children in malaria endemic areas, malaria is one of the 
major causes of anemia and malarial anemia accounts for about a third of all deaths from 
the disease (82). More importantly some authors have suggested that iron 
supplementation in malaria endemic areas may increase malaria or mortality risk. In a 
randomized trial conducted in Zanzibar (83) an increased risk of death or hospitalization 
among children receiving iron and folic acid supplement was found, compared to placebo 
group and it was concluded that while anemic and iron deficient children may have some 
benefit from the iron supplementation, iron replete children may find it harmful. 
However, Ojukwu et al. (84) have concluded in a Cochrane review that with malaria 
surveillance and treatment services in place, there is no increased risk of malaria or death 
with iron supplementation in malaria endemic areas.  
Fortification  
The effect of iron fortified foods on iron status in different populations has been 
widely studied. A six month intervention study using NaFeEDTA fortified fish sauce 
resulted in improved iron status biomarkers and reduced iron deficiency anemia 
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prevalence among Vietnamese women (85). Other similar studies have also shown a 
positive impact of iron fortification on iron status (86-88). These studies have used 
vehicles such as sugar, curry powder, and candy fortified with iron to improve iron status 
of subjects. While food fortification is not as fast as supplementation in addressing 
nutrient deficiency, it is an effective approach and its impact is much more sustainable in 
the long-term. It requires the identification of a food vehicle that is commonly consumed 
by the target population and has a high bioavailability. Also the food fortificant must not 
alter the organoleptic properties of the food, must be widely available, cost-effective and 
must be well absorbed (53, 55).  
An alternative form of fortification is biofortification. With biofortification, plants 
are bred to increase their nutritional value. Few studies have investigated the potential of 
iron biofortified crop in improving iron nutritional status (89, 90). In one such study 
among Filipino nuns, the investigators found that the biofortified rice significantly 
improved ferritin and body iron levels among subjects who were nonanemic (89). 
Biofortication has the advantage of a low recurrent cost. It is also a sustainable approach 
to addressing iron deficiency (91). Also since it is usually done with staple crops, the 
product has a high chance of being predominantly consumed by the poor and people most 
vulnerable to nutritional deficiencies. In addition crops that are biofortified to become 
nutrient dense have the added advantage of been more resistant to diseases. A major 
challenge in the use of biofortification to address micronutrient deficiency in general is 
the acceptance of the new variety, especially where there are visible changes in 
appearance characteristics such as color of the staple (92).  
27 
 
 
 
Food based approach   
Apart from supplementation and food fortification, iron nutritional status in a 
population can also be improved through food based approach. While iron 
supplementation represents a short-to-medium term approach to addressing iron 
deficiency and anemia, food fortification and dietary diversification represent medium-to-
long term approaches (93, 94). Patterson et al. (94) compared the effect of a dietary 
treatment with iron supplementation in improving iron status among iron deficient 
women of childbearing age. The subjects were randomized to either receive 105 mg/d of 
inorganic iron from ferrous sulfate, or an iron rich diet with 2.25 mg/d of absorbable iron 
for 12 weeks. They found that although the iron supplementation improved ferritin levels 
faster (from 9 to 25 µg/L) than the diet (from 9 to 11.0 µg/l), the ferritin level in the high 
iron diet group continued to increase during the 6 month follow up period. Verrall et al. 
(95) investigated a food-based approach to improve iron nutritional status among 
Canadian infants. They conducted repeated cross sectional surveys at two different time 
points to evaluate the impact of an intervention involving the dissemination of 
information aimed at promoting the use of optimal iron-rich complementary foods. They 
used posters, newsletter articles, pamphlets and homemade infant food cooking activities 
as communicating strategies. They found a significant increase in iron intake from 
complementary foods between the two time points. 
Typically, increasing overall food intake is associated with an increased intake of 
iron as well as other nutrients. This is particularly important where overall food intake or 
food security is poor. In such cases, multiple micronutrient deficiencies may also co-exist 
and thus ensuring adequate food availability should be a priority (96). Increasing the 
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intake of iron rich foods is key in addressing iron deficiency in particular. The 
bioavailability of the iron from the food is of utmost importance in addressing iron 
deficiency. In countries where iron deficiency prevalence is high, poor bioavailability is 
considered one of the major causes of iron deficiency (97). To ensure the adequacy of 
iron intake, animal source foods, as well as plant based iron consumed together with 
fruits and vegetables rich in vitamin C must be regular components of the diet. Dietary 
inhibitors of iron absorption must not be consumed together with the iron containing 
meal, especially for plant-based diets. Inhibitors of iron absorption include polyphenols 
from beverages such as tea and coffee, phytic acid which is mostly found in whole grain 
legumes and nuts, and calcium salts. Strategies to reduce the effect of these inhibitors 
includes consuming tea at least two hours after consuming the meal, soaking, germinating 
or fermenting grains to minimize the phytate content, and avoiding the ingestion of 
calcium supplement or dairy products high in calcium together with the iron containing 
meal (96, 98).  
Estimating Prevalence of Inadequate Iron Intake 
Prevalence of inadequate nutrient intake is an estimation of the proportion of the 
population whose intake of the nutrient is less than their requirement. Over the years 
various approaches have been used to estimate this prevalence including the use of 
various proportions of the RDA and other dietary reference values. The RDA is one of 
several Dietary Reference Intakes (DRIs) and is defined as the average daily dietary 
intake level, sufficient to meet the nutrient requirements of nearly all (97-98 percent) 
healthy individuals in a group (99). However, using selected cut-offs based on the RDA 
(such as 50 %, 66 % or 70 % of RDA) cannot be justified especially when used at the 
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population level. Apart from the RDA, the other DRIs are the Estimated Average 
Requirement (EAR), the Adequate Intake (AI) and the Tolerable Upper Intake Level 
(UL). Recently, the EAR cut-point method was introduced as a more efficient and 
unbiased way of assessing prevalence of inadequate nutrients intake in a population 
(100). In this approach, prevalence of inadequate nutrient intake is estimated as the 
proportion of individuals whose usual intake level is below the EAR. The EAR is the 
average daily nutrient intake level estimated to meet the requirements of half of the 
healthy individuals in a group (99). It is estimated as RDA -2SD (of requirement) (101). 
Using the EAR cut-point method requires that certain assumptions be met. These are:  
I. Intake of and requirement for the nutrient are assumed to be independent;  
II. The requirement distribution is symmetrical around the EAR; and  
III. The variability in intakes among individuals in the group is greater than 
the variability in requirements of the individuals.  
Also, the actual prevalence of inadequacy should not be too low (below 8-10 %) 
or too high (90-92 %) (101). It is well-known that the nutrient intake of individuals vary 
from day to day. Similarly when averaged over time, there are differences in the intakes 
of these nutrients between individuals. It is important that before assessing the prevalence 
of inadequate nutrients intake, nutrients intake data is corrected for within person (day-to-
day) variability. This is done to give a good estimate of the usual intake distribution of 
the nutrient in that population. The usual intake is defined as the long-run average of 
daily intakes of the nutrient or a dietary component by an individual (102). Typically in 
dietary assessment, food intake data are collected over a number of days in many cases 2 
or 3 non-consecutive days including at least a weekday and a weekend. While the mean 
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of these intakes may be an unbiased estimator of the usual intake, the variance will not. 
For this reason the distribution of the daily intakes will not accurately represent the 
distribution of usual intakes.  This is because the daily intake distribution will have a 
higher variability than the usual intake distribution due to day-to-day variability. This 
also implies that if you use the mean intake or daily intake distribution to estimate the 
proportion of individuals with intake above or below a given cut point on the distribution 
curve, the results may not be accurate since some parameters of the distribution may 
differ between the mean intake distribution and the usual intake distribution. Nusser et al. 
(103) proposed a method for estimating usual intake distribution using the method of 
moments. Without transforming the data, this method estimates the usual distribution 
using the measurement error model. The moments for the usual intakes are then estimated 
using method of moments. These are then used to estimate the parameters of the 
distribution of usual intakes. Another approach for estimating the usual intakes was 
recommended by the National Research Council (NRC) (104). This method consisted of 
transforming the data, then fitting the measurement error model to estimate the within 
and between person variability and then back transforming the data into the original 
scale. The limitations of the NRC measurement error model includes the fact that 
transforming and back transforming the data may introduce bias in the estimate of the 
usual intake. Moreover, log transformation does not necessarily guarantee normality of 
the data (105). This method was improved upon by Nusser et al. (102) in a method 
popularly referred to as the Iowa State University (ISU) method. In this approach to 
estimating usual intake distribution, the data is first cleaned to remove the effect for noise 
variables such as day of the week. In this step, the intake data is adjusted to the first day 
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data. In the second step, survey weights are incorporated into the analysis to account for 
complex survey designs. The next step involves the transformation of the weight adjusted 
data using a combination of methods (power transformation, and grafted polynomial 
function). The data is first transformed using the power transformation and then mapped 
to the normal scale using the cubic spline transformation (105). Using the transformed 
data, the parameters of the usual intake distribution are then estimated. Like the previous 
methods, the ISU method also uses a measurement error approach in estimating the 
parameters of the usual intake distribution. The estimated usual intake distribution is then 
back transformed in a manner appropriate to the distribution of individual means (102).  
Apart from these methods, the National Cancer Institute (NCI) also developed a new 
approach for estimating usual intake distributions using a mixed effect model.  The NCI 
method uses Box-Cox transformation and covariates in estimating the usual nutrients 
intakes. The percentiles for the usual intake distribution are estimated using the Monte 
Carlo simulation method (106).  Once the data is corrected for the day-to-day variability, 
the usual intake data can now be used to estimate the prevalence of inadequate iron 
intake. Although the EAR-cut point method is a reliable approach for estimating the 
prevalence of inadequate nutrients intake, it does not work for some nutrients because the 
assumptions are not met. For example in the case of iron, the second assumption is 
violated because the requirement distribution is not symmetric around the EAR. Similarly 
in the case of energy, the intake and requirement distributions are not independent, 
violating the first assumption.  
Thus, in estimating the prevalence of inadequate iron intake, the probability 
approach is used (107). In the probability approach, each intake level (interval) is 
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assigned a probability of inadequacy based on a risk curve, and the prevalence of 
inadequate nutrient intake is estimated as the weighted average of the risk (probability) 
values. The risk curve gives the probability that a particular intake level is less than or 
equal to the requirement and is calculated based on the cumulative distribution function 
(CDF) of the requirements for that nutrient (100). To estimate the prevalence of 
inadequate iron intake using this approach (53):  
I. The proportion (%) of the population whose iron intake fell within each 
given risk (probability) of inadequacy is determined.  
II. The different risk values are then multiplied by their respective 
proportions. 
III. The products are then summed up to give the prevalence of inadequate 
intake. 
Iron Bioavailability 
Iron bioavailability is defined as the proportion of the ingested iron that is 
absorbed and utilized for normal physiological functions and storage (24). Iron in the diet 
comes in two different forms, namely heme and nonheme iron. Heme iron comes from 
animal sources whereas nonheme iron is found in both plant and animal sources. 
Approximately 40 % of iron from animal sources is heme iron whereas plant source iron 
are all exclusively nonheme iron. Heme iron is from hemoglobin and myoglobin and is 
better absorbed than nonheme iron. In adults with adequate iron stores, approximately 25 
% of heme iron is absorbed (108). Nonheme iron must first be reduced from the ferric to 
ferrous by DCYTB and then transported across the apical membrane of the enterocytes 
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by DMT1. Heme iron is first transported across the apical membrane by receptor 
mediated endocytosis and the iron is released from heme by HO-1 (28).  
Factors Influencing Iron Bioavailability 
Several factors are known to influence the absorption of iron from the diet. Heme 
iron absorption is more moderately influenced by iron status of the host, but absorption of 
nonheme iron is strongly influenced by iron status and also affected to some extent by 
dietary factors. The dietary factors that influence nonheme iron absorption include 
calcium salts, phytates, ascorbic acid, animal tissue (meat, fish and poultry) and 
polyphenols (beans, coffee and tea). Apart from these, the amount of nonheme iron in the 
diet also has an influence on the percentage absorption with less percentage absorption at 
higher intakes. Ferritin is the most well-known iron status marker that influences iron 
absorption. Other host factors such as hepcidin, inflammation or infection and even 
genetic factors may also be important in the variability of iron absorption among 
individuals. Among the different dietary factors, ascorbic acid and animal tissue (meat, 
fish and poultry) enhance iron absorption while the others (phytic acid, polyphenols and 
calcium salts) inhibit iron absorption.  
Ascorbic acid 
Ascorbic acid is a water soluble vitamin with both enzymatic and non-enzymatic 
functions. In its enzymatic functions, it serves as a cofactor for many metabolic reactions 
including hydroxylation of collagen, tyrosine metabolism, carnitine and norepinephrine 
biosynthesis and peptide hormone amidation. Apart from its enzymatic roles, it serves as 
a strong antioxidant, helping with the scavenging of free radicals and reactive oxygen 
species (109, 110). Fruit and vegetable contribute approximately 90 % of vitamin C 
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intake with high amounts occurring in citrus fruits, kiwi, mango and broccoli. Deficiency 
of vitamin C has been attributed mainly to poor dietary intake, and may also be caused by 
smoking as well as genetic and clinical conditions (109). Most plants and animals 
synthesize ascorbic acid from D-glucose or D-galactose. Humans, however, do not 
synthesize ascorbic acid due to the inactivation of the gene that encodes for the enzyme 
L-gulono-γ-lactone oxidase. Therefore, ascorbic acid must be supplied through the diet 
(111). Vitamin C is a well-known enhancer of nonheme iron absorption. It enhances 
nonheme iron absorption by reducing iron from ferric to ferrous form for efficient 
transport across the apical membrane of the enterocytes. Ascorbic acid is also able to 
chelate iron to form a complex that is soluble over a wide pH range (112). Its enhancing 
effect has been shown in various studies (113). When Kuhn et al. (114) investigated the 
effects of different chelating agents on iron absorption from different foods, they reported 
an increase in iron absorption from corn and from wheat meals after the addition of 
ascorbic acid. Callendar and Marney (115) found that the addition of 100 ml orange juice 
to an egg meal increased iron absorption from 3.7 to 10.4 %.  In another study, the 
addition of papaya containing 66 mg ascorbic acid increased nonheme iron absorption by 
approximately 5 fold (116).  The effect of ascorbic acid on nonheme iron absorption has 
been shown to be dose-dependent (117). Even in the presence of inhibitors, ascorbic acid 
is able to counteract the inhibitory effects. In a study by Hallberg et al. (118) addition of 
50 or 100 mg ascorbic acid significantly increased iron absorption from meals containing 
25 and 250 mg of phytate phosphorus. Ascorbic acid also counteracted the inhibitory 
effects of polyphenols in a study by Siegenberg et al. (119). For meals containing low to 
medium level of inhibitors, an ascorbic acid: iron molar ratio of 2:1 is required to 
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promote iron absorption, while for those with high amounts of inhibitors, a molar ratio of 
4:1 is required (120).  
Animal tissue 
The pioneering work on the enhancing effect of animal tissue on nonheme iron 
absorption is attributed to Layrrise and co-workers (1968). Their work investigated the 
effect of interaction among different food items on iron absorption. They found that 
adding veal muscle or fish to corn increased iron absorption by about 50 and 300 % 
respectively. Similarly adding veal muscle tripled iron absorption from black beans. 
Similarly, when black beans were given with amino acid similar to the combination 
found in fish, there was approximately three fold increase, suggesting that animal tissue 
may enhance iron absorption through the amino acids released during digestion. Since 
then, several other studies have also demonstrated the enhancing effects of animal tissue 
on iron absorption. For example, Bach et al. (121), have shown that adding meat (≥50g) 
to a low bioavailability test meal can increase iron bioavailability by over 40 %. Hallberg 
et al. (122) studied the effect of adding meat (with or without ascorbic acid) to weaning 
gruel on nonheme iron absorption. They found that the addition of meat powder markedly 
increased iron absorption from the gruels by 85 % (from 0.33 mg to 0.61 mg). Hallberg 
and Rossander (123) have also shown that the addition of 75 g meat to low bioavailability 
meal composed of maize, rice and black beans increased nonheme iron absorption from 
0.17 mg to 0.45 mg. Like calcium, animal tissue is also unique in its contribution to iron 
absorption. The heme content of animal tissue is better absorbed, contributing total iron 
absorption. Similarly, animal tissue enhances the absorption of nonheme iron in the meal. 
While the mechanism by which meat enhances nonheme iron absorption is unclear, 
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several possible mechanisms have been proposed. For example, the stimulation of gastric 
juice secretion is one suggested mechanism. When Cook et al. (124) investigated the 
effect of achylia gastrica on iron absorption, they found that mean iron absorption was 
lower in the achylic group as compared to the control group, and the addition of gastric 
juice to the test dose increased iron absorption. Another suggested mechanism is the 
release of digestion products of animal tissue. Hurrell et al. (125) have suggested that 
partially digested products form animal tissue are able to bind iron via their histidine and 
cysteine residues, rendering iron soluble and thus enhancing its absorption. In this way, 
iron is also unavailable for binding with phytates and polyphenols which might be 
present in the meal.  
Phytic acid 
Phytic acid (myoinositol hexakiphosphate, or IP6) is a key inhibitor of iron 
absorption. It is found in high amount in grains, legumes, nuts and oil seeds. Phytic acid 
is the main storage form of phosphorus in seeds. It holds up to 80 % of the seed 
phosphorus (126). The salt form (magnesium, calcium or potassium salt) of phytic acid is 
referred to as phytate (127). Phytate inhibits iron absorption by binding to the iron to 
form insoluble complexes that cannot be absorbed at the intestinal pH (128).  The 
negatively charge phosphate in the phytic acid structure binds to metallic cations 
including iron, calcium and zinc, rendering them insoluble and impairing their 
bioavailability. In many developing countries where iron deficiency prevalence is high, 
dietary staples are also known to contain high phytate level of phytate compared to 
developing countries. For instance, according to Amirabdollahian and Ash (129), median 
phytate intake among adults in the United Kingdom is 809 mg/day, while the estimated 
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phytate intake in Nigerian diet is approximately 2200 mg/day. The average phytate intake 
among US aldults is estimated to be about 750 mg/day (130).  
Mostly, the higher inositol phosphates (myo-inositol hexaphosphate-IP6 and myo-
inositol hexaphosphate IP5) are responsible for the inhibitory effects of phytates on iron 
absorption. In an experiment to determine the effect of inositol phosphates with different 
number of phosphorus groups on iron absorption, Sandberg et al. (131) found that IP5 
inhibited iron absorption but no effect with IP4 and IP3 was observed. In vitro studies 
have also shown  that while even small amounts (0.5 µmol) of IP5 and IP6 reduce iron 
solubility significantly, IP3 and IP4 did not (132). Like ascorbic acid, the effect of phytic 
acid on nonheme iron absorption is dose dependent (133).  
In high phytate meals, iron absorption can be increased by reducing the phytate 
content. In a study by Hurrell et al. (134) when phytate contents of soy protein isolates 
were reduced from 4.9-8.4 mg/g to ≤ 0.01 mg/g by either enzymatic treatment or acid 
washing and ultrafiltration, iron absorption improved as much as four to five fold. 
Phytate content of foods can be reduced through soaking, germination, fermentation, and 
addition of phytase enzyme. During germination, there is an increase in phytase activity 
leading to hydrolysis of phytate (IP6) into intermediate inositol phosphates (IP-1, IP-2, 
IP-3, IP-4, and IP-5). This occurs through de novo synthesis of the enzyme or activation 
of endogenous phytase or both (127, 128). In fermentation, the hydrolysis of phytate is 
due to phytases produced by microflora on the surface of cereal grains. Soaking on the 
other hand reduces phytate content in most legumes which have phytates stored in water 
soluble forms such as sodium or potassium phytates (135).  
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Polyphenols 
Polyphenols are a group of natural compounds with phenolic structural features 
(136). They constitute the most common dietary source of antioxidants and are known to 
contributes significantly to human health particularly in the prevention of degenerative 
diseases like cancer, neurodegenerative diseases, diabetes mellitus, cardiovascular 
diseases and osteoporosis (137). Polyphenols may act as both antioxidant and prooxidants 
under different conditions serving different purposes such as improving cell survival and 
triggering programmed cell death (137). Their health benefits however, depends on their 
bioavailability and the amount consumed (138). Polyphenols occur in good quantities in 
fruits, vegetables, whole grains, tea, coffee, chocolate, red wine, legumes and other foods 
(136, 137). Based on the chemical structure of their aglycones, they are classified as 
phenolic acids, flavonoids, polyphenolic amides, and other polyphenols (138, 139).  
Phenolic acids constitutes of benzoic and cinnamic acid derivatives. They are 
non-flavanoid polyphenols. Examples are caffeic acid and chlorogenic acid. Flavonoids 
on the other have two aromatic rings bound together by three carbon atoms (138). 
Flavonoids consist of six subtypes named based on the type pf heterocycle they contain. 
These are anthocyanidins, flavones, flavanones, flavonols. Isoflavones and flavanols 
(cathechins and proanthocyanins). Flavanols may exist as monomeric (Catechins), 
dimeric (Theaflavins) or polymeric (proanthocyanidins). Catechins are found 
predominantly in green tea, chocolate, red wine and fruits such as apricot. Theaflavins 
and thearubigins are formed by the oxidation of monomeric flavanols in black tea during 
fermentation (138).  
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Polyphenol amides have N-containing functional substituents. Examples are 
capsaicinoids found in chili peppers and avenanthrmides in oats. Other polyphenols apart 
from the phenolic acids, flavonoids and phenolic amides include resveratrols, ellagic acid 
(dimer of gallic acid), hydrolysable tannins (glucose esters of gallic acid and ellagic 
acid), rosemarinic acid. Despite their role in human health, polyphenols are also known to 
possess anti nutrition properties. They are known as major dietary inhibitors of iron 
absorption (140). Polyphenols inhibit iron absorption by binding and forming complexes 
with iron within the intestinal lumen, after their release from the meals (141). This 
activity of polyphenols is mainly attributed to galloyl groups in polyphenols(142). 
In a pioneering study, Disler et al. (143) investigated the effect of tea on iron 
absorption among multiparous housewives with a mean age of 40 years. They measured 
iron absorption from a test meal consumed alongside tea or water. They found that tea 
consumption inhibited iron absorption from different iron solutions (FeCl3 and FeSO4) as 
well as from bread and a rice meal. The results were attributed to tannins in the tea. 
Brune et al. (142) also investigated the importance of different phenolic structures in iron 
absorption. They found that tannic acid inhibited iron absorption in a dose-dependent 
manner, and to a similar extent as gallic acid. However, their findings suggested no 
inhibitory effect of catechin on iron absorption. In another study, Hurrell et al. (141) 
determined the effect of different polypohenol-containing beverages on iron absorption 
from a bread meal. Unlike Brune et al. (142) their study suggested that all major types of 
food polyphenols including chlorogenic acid, flavonoids, gallic acid, are potential 
inhibitors of nonheme iron absorption. Inhibition was highest with black tea (up to 94 %), 
and least with the herbal tea, camomile (47 %). Black tea is known to contain 10 % 
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flavonols, 25 % catechins, 20 % theaflavins and 45 % thearubigins (144). Tuntawiroon et 
al. (145) also investigated the dose-dependent inhibitory effects of food polyphenols on 
nonheme iron absorption using Yod Kratin, a popular Thailand vegetable high in 
polyphenols (29.2 mg tannic acid equivalents per gram). They found that 20g of this 
vegetable (common serving size) could reduce iron absorption by approximately 90 % 
due to the high galloyl group content which is known to bind iron and inhibit its 
absorption. It has been shown that the inhibitory effect of polyphenols occurs when they 
are consumed together with the meal and that tea may inhibit iron absorption by forming 
complexes with the iron (146). 
Calcium  
Calcium is considered an essential element in human nutrition because it must be 
supplied to the body through the diet. The adult body contains approximately 1 kg of 
calcium which is mostly found in the skeleton where it provides skeletal support (147). In 
the United States, dairy products supply over 70 % of calcium intake (14). The inhibitory 
effect of calcium is has been well investigated in both human and animal studies. Deehr 
et al. (148) investigated the effect of different sources of calcium on iron absorption 
among 19 postmenopausal women. They found mean body retention of 8.3 % from the 
placebo. In the other treatments containing calcium from different sources, absorption 
was lower.  Cook et al. (149) investigated the effect of three widely used calcium 
supplements (calcium carbonate, calcium citrate and calcium phosphate) on the 
absorption of nonheme food iron and also on the absorption of ferrous sulfate taken 
without food in adults with results supporting an inhibitory effect of calcium especially 
from an inhibiting meal.  
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Calcium is unique among the dietary factors that influence iron absorption in that 
it is the only one with inhibitory effect on both heme and nonheme iron absorption. The 
nature of the inhibition effect of phytate has been described as flat inverse S-shaped, with 
no inhibition at <40 mg calcium in the meal and no further inhibition when calcium 
content exceeds 300 mg (150). This is based on a study in which Hallberg et al. (151) 
investigated the effect of different amounts of calcium on iron absorption. Iron absorption 
in this study was measured when a radiolabeled wheat roll contained no or known 
amounts of calcium added as calcium chloride either before or after baking. However, 
there is still uncertainty about how calcium interferes with iron absorption. Lynch (14) 
has suggested that the inhibitory effect of calcium on iron absorption may be explained 
by an interaction between calcium and food components that affect iron bioavailability or 
an effect of calcium on luminal surface receptors involved in iron uptake. However, 
Hallberg et al. (151) have suggested that the effect of calcium may be at the mucosal 
level, at a process common to both heme and nonheme iron.  
Estimating Iron Bioavailability 
There are many different approaches to assessing iron bioavailability. Based on its 
definition, bioavailability comprises of the digestibility (solubility), absorbability 
(absorption) of the iron and the utilization or its incorporation into a functional 
compartment or system (152). 
Chemical balance method 
The chemical balance method is an indirect measure of the iron retained in the 
body after ingestion. Apparent iron absorption is calculated from this method as the 
difference between iron intake and the fecal iron. This may be corrected by subtracting 
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the urinary iron to estimate iron retention. Essentially since the urinary iron is minute, the 
retention iron and the apparent absorption are similar (152). This method has however 
been described as time consuming, insensitive and lacking precision owing to challenges 
such as incomplete fecal collection (9).  
Solubility/dialyzability 
The solubility approach to assessing iron bioavailability deals with only nonheme 
iron since heme iron is directly absorbed and enters the enterocyte as heme. In in vitro 
solubility measurement, the food sample is first treated with HCl to adjust the pH to two, 
after which it is digested with pepsin. After the pepsin digestion, the pH is adjusted to six 
and the sample is digested again with pancreatin. The soluble iron that is released is then 
measured in the supernatant after centrifugation (153). Iron dialyzability is a modification 
of the iron solubility method. This method involves the fractionation of the sample using 
a dialysis bag. The dialysis bag contains a base such as NaHCO3 or PIPES buffer that 
gradually increases the pH to the level suitable for the action of the intestinal enzymes. 
This method measures dialyzable iron (the soluble iron with less molecular weight than 
the cut off of the dialysis tube) (152, 154-156). Iron solubility methods have the 
limitation that they only measure a part of the bioavailability concept, not taking into 
account the absorption and utilization components. Also dialyzability may not measure 
iron compound with higher molecular weight such as ferritin, although they may be 
absorbed in humans.  
Caco-2 cell model 
Caco-2 cells are human adenocarcinoma cells used widely in iron absorption 
studies. In the cell culture model, cells grown in a cell culture media at 37oC and CO2 
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concentration of 5 % are used in an iron uptake experiment. The test meal is digested in 
vitro as is done in iron solubility. The cells are then treated with the digested test meal to 
measure iron uptake from the digest by the cells (153). Despite minor discrepancies in the 
magnitude of the effects of dietary factors on iron absorption, the Caco-2 cells model has 
been demonstrated to correlation well with human absorption study data (153, 157). In 
one of such studies, Yun et al. (171) measured iron absorption using the Caco-2 cell 
model and compared the results to published studies on iron absorption measured in 
humans. They measured iron absorption from the meals when they contained ascorbic 
acid and tannic acid and also measured iron absorption when the foods these dietary 
factors were not added to the meal. They found a strong positive correlation between 
absorption ratio measured using the Caco-2 cell model and that determine in the human 
studies using extrinsic tagging (r = 0.986, P < 0.001). Although there are limitations to 
this model, it remains the best cell model for assessing iron bioavailability.  
Hemoglobin repletion method 
The rat hemoglobin repletion method is a standard method used by the 
Association of Official Analytical Chemist (AOAC) (158). It is usually used to determine 
the relative bioavailability value of a test iron compound in comparison with ferrous 
sulfate. In this method, male rats are kept on an iron depleted diet for a period of time and 
then fed an iron replete diet (containing the iron compound to be tested) for a period of 
time to improve their iron status (159, 160). Rats are usually housed individually in wire 
bottom stainless steel cages. They are kept under a 12-hour light-dark cycle. Food and 
deionized water are provided ad libitum over the entire study period (161). Blood 
collection before and after repletion is done using various methods including tail incision, 
44 
 
 
 
orbital socket blood draw and cardiac puncture. In analyzing the data, changes in 
hemoglobin or hemoglobin iron during the repletion period is plotted against either iron 
intake or the iron level of the diet. In the slope ratio analysis, a single multiple linear 
regression model is constructed using the control (the no iron diet group) as the blank.  
This is done using the common intercept model. The slope for the test and the ferrous 
sulfate treatment are determined, and compared. The mean of the blank is compared to 
the intercept to determine if they are significantly different (159, 160). The hemoglobin 
repletion method is also used in piglets, however the use in rats is most common (162).  
Isotopic methods 
The isotopic methods are the most common methods for assessing iron 
bioavailability. The most accurate method is intrinsic labeling. In this method, the food is 
biosynthetically labeled with a radioisotope of iron. Despite its reliability, preparing the 
labeled food in the intrinsic tagging method is a difficult task. Cook et al. (163) found 
that iron absorption could also be measured with extrinsic tagging in which the food is 
labeled with the iron isotope during the iron absorption measurement. When they 
compared iron absorption measured by the two different methods, the results were same. 
Since extrinsic tagging is less cumbersome, it therefore became more popular than the 
intrinsic tagging method. This method is based on the underlying principle that all the 
nonheme iron from a given meal form a common pool and are absorbed with equal 
efficiency, thus implying uniform labeling of all the nonheme iron from the different 
components of a meal by a stable or radioactive tracer (9). There are two common 
techniques for measuring iron bioavailability using the extrinsic tagging method. These 
are the whole body counting method and the red cell radioiron incorporation. In the 
45 
 
 
 
whole body counting method, a radioisotope of iron is administered with the test meal or 
the diet. For this method, 59Fe is used because 55Fe the other radioisotope of iron does not 
emit gamma radiations. A count of the radioisotope is made shortly (usually one hour) 
after the ingestion of the radiolabeled meal or diet to serve as the baseline count. This 
count is assumed to be 100 % (152, 164). The counts are taken again at approximately 10 
to 14 days.  After the first count, there is a continual decrease in 59Fe as a result of fecal 
excretion. After 10-14 days, it is said to have reached equilibrium. The retained 59Fe is 
estimated as the ratio of the final count at any given time to the initial count, expressed as 
percentage. The percentage iron absorption is calculated by first plotting a curve of the 
retention vs time and then extrapolating the straight line portion of the curve to the zero 
time (T = 0).  
In the red cell incorporation method, subjects are fed a test meal that is labeled 
with either radio (55Fe or 59Fe) or stable (57Fe or 58Fe) isotopes of iron after an overnight 
fast. After consuming the test meal, subjects are required to abstain from food (only water 
allowed for the next several hours). Blood samples are collected two weeks after the test 
meal consumption to measure radioactivity in the blood. The absorption is usually 
calculated in comparison to absorption from a reference meal. Generally, the assumption 
is that at least 80 % of the absorbed isotope is incorporated into the red blood cells in two 
weeks (164). 
Area under the curve for serum iron 
This method is commonly used in pharmaceutical companies who use one of two 
post absorption measurements namely area under the curve or maximal concentration 
after drug/nutrient administration. It is a good method for comparing the absorption of 
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two to three compounds in the same subject. In the serum iron curve method, post 
absorptive serum iron curve is constructed by collecting baseline blood sample, followed 
by test meal/compound administration and then the collection of multiple blood samples 
thereafter at regular time intervals (152). Blood samples are analyzed for serum iron and 
the curve for serum iron over time is constructed. The area under the curve for each 
subject is used as a measure for iron bioavailability. This approach was validated by 
Conway et al. (165). They reported a strong positive correlation between absorption 
measured by AUC and erythrocyte incorporation. Apart from the AUC, Conway et al. 
(165) also estimated iron bioavailability using the maximum value for serum iron in the 
serum iron curve, and also used values at 180 and 210 minutes. Of these options, they 
found that the maximum iron recovery at maximum gave the highest correlation with the 
erythrocyte incorporation of iron isotope.  
Algorithms 
Several statistical models have been developed recently for estimating iron 
bioavailability from diets. These are necessary because in population studies, the isotopic 
and other clinical measurements of iron absorption are not feasible, but rather laborious 
and expensive. Monsen et al. (108, 166) developed a model to estimate the bioavailability 
of dietary iron. Their model was based on iron absorption from heme and nonheme iron 
sources. For heme iron sources, percentage absorption is assigned based on level of iron 
stores, with 0, 250, 500 or 1000 mg iron stores corresponding to 35, 28, 23 and 15 % 
absorption respectively. This was based on the fact that heme iron absorption is 
influenced mainly by body iron levels and not by dietary factors. For nonheme iron, 
estimation of absorption was based on the levels of two different enhancers, namely 
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ascorbic acid and animal tissue in the meal. These enhancers were the ones well studied 
at the time of their model. Depending on the amount of ascorbic acid and animal tissue in 
the meal, nonheme iron absorption was classified as high (8 %), medium (5 %) or low (3 
%).  In estimating iron absorption using this model, the total, heme and nonheme iron 
levels as well as the ascorbic acid and the animal tissue levels must be known. To 
estimate iron absorption from a day’s meal, the iron absorption is first estimated for each 
single meal and snack separately, after which the iron absorption values are tallied up. 
This model was limited in that it did not include the effect of dietary inhibitors. The 
model was modified by Tseng et al. (167) to further adjust for the effect of tea and phytic 
acid. Du et al, (8) also developed a new algorithm after finding out that the existing 
algorithms of that time did not accurately predict iron bioavailability. Their new model 
incorporated ascorbic acid, animal foods, fruits, vegetables, beans, rice and tea. In that 
same year, both Reddy et al. (26) and Hallberg et al. (140) developed new algorithms. 
Hallberg’s model was based on iron absorption from a basal meal multiplied by the effect 
of different dietary factors. The dietary factors considered in their model were phytate, 
polyphenols, soy protein, calcium, eggs, ascorbic acid, meat, and alcohol. The basal meal 
was a wheat roll that contains no inhibitors or enhancers of iron absorption. Absorption 
from this wheat roll was adjusted to that from a reference dose of 40 %. The wheat roll is 
made from low extraction wheat flour which has been well fermented to remove all 
inositol phosphates as much as possible.  The effect of the different dietary factors were 
based on equations developed from absorption measurement made from the basal meal 
with and without the dietary factor at different levels. Their model also considered 
interactions between different dietary factors. A major limitation of this algorithm 
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however was its complexity. Also their use of a wheat roll without any dietary inhibitors 
in measuring absorption was not realistic. Reddy's algorithm was developed using data 
from iron absorptions studies in which iron absorption was measured from 25 different 
meals among 86 subjects. Absorption values were adjusted to a ferritin level of 30 µg/L 
prior to the development of the model. They developed the model using multiple linear 
regression. After excluding polyphenols, calcium and nonheme iron intake due to lack of 
statistical significance in the model, the ascorbic acid, animal tissue and phytic acid 
remained as the significant predictors of nonheme iron bioavailability from the meals. 
Their data suggested that these dietary factors accounted for only about 16 % of 
variability in dietary iron bioavailability. Other authors have also developed other 
algorithms since then (12, 168, 169). The algorithm by Conway et al. (168) was based on 
food group consumption. They used published data in which iron absorption was 
measured from single meals labeled with radio-isotopes of iron. They adjusted iron 
absorption from these studies to correspond to 40 % absorption from a reference dose of 
3 mg iron. This adjustment corresponds to iron absorption among subjects with 
borderline iron deficiency. Their model included the following food groups: animal 
tissue, high vitamin C fruit/juice, beans and lentils, whole grain cereals, tea, dairy, 
cheese, eggs, nuts and soya. Their algorithm explained 22 % of the variability in 
nonheme iron absorption. The algorithm developed by Rickard et al. (170) estimated 
available iron from the meal  adjusting for the effect of ascorbic acid, phytate, meat, fish 
and poultry, calcium and polyphenols from tea. They also included nonheme iron intake 
as an inhibitor in their model considering that high intake of nonheme iron leads to a 
lower percentage nonheme iron absorption in the gut. They used data on iron absorption 
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measured using the serum iron curve for a total of 228 test meals to develop this 
algorithm using selected non-linear functions. To estimate nonheme iron absorption using 
their model, a constant is first multiplied by the effect of each of two enhancers (ascorbic 
acid and animal tissue). The result is then divided by the effect of each inhibitor (phytate, 
polyphenol, calcium and nonheme iron). Their model explained 45 % of the variability in 
iron availability. When they used their model as well as those by Hallberg et al. (140) and 
Reddy et al. (26) to predict iron availability form an independent dataset, their algorithm 
gave values within reasonable range (5-35 %) while those by the two other models 
included predictions above 100 %. However, like other existing models, theirs was also 
developed from single meal studies data (165). The most recent algorithms were 
developed by Armah et al. (25) and Colling et al. (12). The model of Armah et al. (25) 
was based on published data from complete diet studies which investigated the effect of 
different dietary factors on iron absorption from a complete diet. The factors were meat, 
calcium, tea and ascorbic acid. In each of the four studies, the effect of the dietary factor 
was measured when subjects consumed typical, high or low levels of the factor in a five 
day diet. Iron absorption was measured using radioisotopes of iron (55Fe and 59Fe). Using 
a mixed effect model, they developed an equation that estimates the percentage of 
nonheme iron absorption from vitamin C, meat, calcium, tea (in cups as black tea 
equivalents), phytate, nonheme iron and also serum ferritin. This model was validated 
using both complete and single meal data from published studies with R-squared values 
of 84 and 57 % for complete diet and single meal data respectively. Their model 
suggested that serum ferritin was the most important factor predicting iron absorption 
among all the explanatory variables included in their model, while the contribution of 
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dietary factors was small. Collings et al. (12) also recently developed a regression model 
that estimates nonheme iron absorption using serum ferritin concentration and the 
presence or absence of a dietary modifier. Their model was based on data from 5 
published complete diet studies including a total of 58 subjects. Based on this model, they 
estimated the level of nonheme iron absorption for people with different ferritin levels. 
Their predicitions suggested that nonheme iron absorption could range from 1.8 to 23 % 
among individuals with ferritin 6-100 µg/L, depending on the nature of their diet. Their 
model suggested that the effect of dietary factors is more pronounced when iron status is 
poor (low ferritin) and less pronounced among individual with high iron status.  
Performance of Existing Algorithms in Predicting Iron Absorption from Diets 
Various authors have compared the different algorithms for their ability to predict 
iron absorption from the diet. In one such studies, Beard et al. (171) predicted iron 
absorption from the diets of Filipino nuns using six published algorithms (8, 26, 140, 166, 
167, 169). Absorption values estimated using the different algorithms were lower than 
expected even when they estimated absorption for only subjects with ferritin less than 20 
µg/L. Hunt (24) assessed the performance of six different published algorithms (8, 26, 
140, 166, 167, 169) in predicting nonheme iron bioavailability from complete diets. She 
normalized the nonheme iron absorption values (both the observed and predicted values) 
to a ferritin level of 23 µg/L. While the Monsen algorithm (108, 166) predicted nonheme 
iron absorption from the high bioavailability diets well, the algorithms by Reddy (26) and 
Hallberg (140) better predicted the low bioavailability diets and overestimated absorption 
for high bioavailability diets. While the algorithms by Tseng (167) and Bhargava (169) 
underestimated nonheme iron absorption from the different diets, the remaining 
51 
 
 
 
algorithms mostly overestimated. The best prediction of nonheme iron absorption 
according to the author was by the Hallberg model. In another study to investigate the 
role of low bioavailability diets in the development of iron deficiency among Moroccan 
children, Zimmermann et al. (11) estimated the percentage iron absorption from the diets 
of children 6-10 years old. They used the algorithms developed by Reddy et al. (26) and 
Tseng et al. (167) to estimate nonheme iron absorption setting heme iron absorption at 
23, 28 and 35 % for high, medium and low iron stores respectively. The authors reported 
that the algorithm by Reddy et al. (26) gave a better prediction despite the fact that it was 
developed based on western type diet. Based on their estimation, iron absorption among 
the subjects was 0.22 mg/day, while the two algorithms predicted 0.21 mg/day and 0.55 
mg/day for the Reddy (26) and Tseng (167) algorithms respectively. Since these 
comparisons of algorithms were published further new algorithms have been developed 
by Armah et al. (25) and Colling et al. (12) which have already been described above. 
Armah et al. (25) validated their model using published (independent) data, the resulting 
R-squared for single meal and complete diet data were 57 and 84 % respectively. The 
authors reported that their model overestimated nonheme iron absorption by 1.87 % 
which they attributed in part to the lack of complete data for the validation, citing the use 
of group means instead of individual dietary intake and serum ferritin values.  
Single vs. Complete Diet Absorption Studies 
Many of the existing studies on the effect of dietary factors on iron absorption 
were performed using single meals. In single meal studies, iron absorption is measured 
from a single test meal that is labeled with an isotope of iron. Alternatively, iron 
absorption from a whole diet can be measured. The whole diet refers to multiple meals 
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such as all foods consumed in a day or number of days. In such cases, each meal 
component of the diet is labeled with the isotope of iron for iron absorption measurement. 
Studies have shown that when iron absorption is measured from the whole diet, the effect 
of dietary factors is less pronounced compared to what is observed in single meal 
absorption studies. In a study to compare iron absorption from single and complete diet 
studies, Cook et al. (27) measured iron absorption from both single meals and a two week 
diet among 45 subjects. Subject consumed either self-selected, enhancing or inhibiting 
diet for two weeks (n = 15 per diet). Iron absorption was measured from the two week 
diet as well as a single meal reflecting their respective diets (self-selected, inhibiting or 
enhancing meal). The outcome of their study showed that single meal absorption 
measurement give exaggerated estimates of the effect of dietary factors on nonheme iron 
absorption. Among those consuming self-selected diet iron absorption were similar when 
measured from single meal and complete diets. However, among those consuming the 
enhancing diet, while the single meal absorption measurement was 11.1 %, two week diet 
absorption was 6.6 %. Also in the inhibiting group, while the single meal showed iron 
absorption of 2.5 %, the complete diet absorption was 3.4 % suggesting the effect of the 
inhibitors was less than seen in the single meal absorption measurement. In another study 
among women with low iron stores, Hunt et al. (172) have shown that the effect of 
ascorbic acid on iron absorption from the diet is less than what is seen in single meal 
studies. This is also supported by observation made by Cook et al. (173) who assessed the 
effect of ascorbic acid on nonheme iron absorption from a complete diet.  While the 
reason for the discrepancy between single and complete diet absorption values is not well 
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understood a possible explanation for this observation in short-term studies is the residual 
effect of previously consumed meal components. 
Conclusion 
This review has covered iron metabolism, its function and the assessment and 
consequences of iron deficiency as well as strategies to address iron deficiency in 
populations. One key factor that contributes to iron deficiency in developing countries is 
iron bioavailability. We have discussed iron bioavailability and its assessment, as well as 
the dietary factors that influence the bioavailability of dietary iron. Many of these factors 
show a dose dependent relationship in their effect on iron bioavailability. Among the 
enhancers, the effect of ascorbic acid is more prominent and is able to counteract the 
inhibitory effects of both polyphenols and phytic acid. The enhancing effect of animal 
tissue is rather moderate, however with the associated heme iron, it contributes to total 
available iron, making it equally important in improving the intake of available dietary 
iron. It is also clear from this review that when measured from the whole diet, the effects 
of dietary factors are dampened compared to single meal absorption measurement. While 
there are suggested reasons, including adaptation and the residual effects of previous 
meals, data explaining the mechanisms are scanty, warranting future studies.  
References 
1. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and 
disease. Mol Aspects Med. 2001; 22:1-87.  
 
2. Lane DJ, Richardson DR. The active role of vitamin C in mammalian iron 
metabolism: Much more than just enhanced iron absorption! Free Radic Biol 
Med. 2014; 75C:69-83.  
 
3. Ajioka RS, Phillips JD, Kushner JP. Biosynthesis of heme in mammals. 
Biochimica et biophysica acta. 2006; 1763:723-36.  
 
54 
 
 
 
4. Steinbicker AU, Muckenthaler MU. Out of balance--systemic iron homeostasis in 
iron-related disorders. Nutrients. 2013; 5:3034-61.  
 
5. Beard JL. Iron biology in immune function, muscle metabolism and neuronal 
functioning. J Nutr. 2001; 131:568S-79S; discussion 80S.  
 
6. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control 
of mammalian iron metabolism. Cell. 2004; 117:285-97.  
 
7. Dunn LL, Suryo Rahmanto Y, Richardson DR. Iron uptake and metabolism in the 
new millennium. Trends Cell Biol. 2007; 17:93-100.  
 
8. Du S, Zhai F, Wang Y, Popkin BM. Current methods for estimating dietary iron 
bioavailability do not work in China. J Nutr. 2000; 130:193-8.  
 
9. Hallberg L. Bioavailability of dietary iron in man. Annu Rev Nutr. 1981; 1:123-
47.  
 
10. Boech SB, Hansen M, Bukhave K, Jensen M, Sorensen SS, Kristensen L, Purslow 
PP, Skibsted LH, Sandstrom B. Nonheme-iron absorption from a phytate-rich 
meal is increased by the addition of small amounts of pork meat. Am J Clin Nutr. 
2003; 77:173-9.  
 
11. Zimmermann MB, Chaouki N, Hurrell RF. Iron deficiency due to consumption of 
a habitual diet low in bioavailable iron: a longitudinal cohort study in Moroccan 
children. Am J Clin Nutr. 2005; 81:115-21.  
 
12. Collings R, Harvey LJ, Hooper L, Hurst R, Brown TJ, Ansett J, King M, 
Fairweather-Tait SJ. The absorption of iron from whole diets: a systematic 
review. Am J Clin Nutr. 2013; 98:65-81.  
 
13. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, Sandoval C, 
Zhao R, Akabas MH, Goldman ID. Identification of an intestinal folate 
transporter and the molecular basis for hereditary folate malabsorption. Cell. 
2006; 127:917-28.  
 
14. Lynch SR. The effect of calcium on iron absorption. Nutr Res Rev. 2000; 13:141-
58.  
 
15. Andrews NC. The iron transporter DMT1. Int J Biochem Cell Biol. 1999; 31:991-
4.  
 
16. Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J 
Biochem Cell Biol. 1999; 31:1111-37.  
 
55 
 
 
 
17. Chahine JMEH, Pakdaman R. Transferrin, a mechanism for iron release. Eur J 
Biochem. 1995; 230:1102-10.  
 
18. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl 
Pharmacol. 2005; 202:199-211.  
 
19. Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron 
storage, antioxidation and more. Biochimica et biophysica acta. 2009; 1790:589-
99.  
 
20. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: 
regulation of mammalian iron metabolism. Cell. 2010; 142:24-38.  
 
21. Miyazaki E, Kato J, Kobune M, Okumura K, Sasaki K, Shintani N, Arosio P, 
Niitsu Y. Denatured H-ferritin subunit is a major constituent of haemosiderin in 
the liver of patients with iron overload. Gut. 2002; 50:413-9.  
 
22. Theil EC. Mining ferritin iron: 2 pathways. Blood. 2009; 114:4325-6.  
 
23. Gourley BL, Parker SB, Jones BJ, Zumbrennen KB, Leibold EA. Cytosolic 
aconitase and ferritin are regulated by iron in Caenorhabditis elegans. J Biol 
Chem. 2003; 278:3227-34.  
 
24. Hunt JR. Algorithms for iron and zinc bioavailability: are they accurate? Int J 
Vitam Nutr Res. 2010;80(4-5):257-62. 
 
25. Armah SM, Carriquiry A, Sullivan D, Cook JD, Reddy MB. A complete diet-
based algorithm for predicting nonheme iron absorption in adults. J Nutr. 2013; 
143:1136-40.  
 
26. Reddy MB, Hurrell RF, Cook JD. Estimation of nonheme-iron bioavailability 
from meal composition. Am J Clin Nutr. 2000; 71:937-43.  
 
27. Cook JD, Dassenko SA, Lynch SR. Assessment of the role of nonheme-iron 
availability in iron balance. Am J Clin Nutr. 1991;54(4):717-22.  
 
28. Franchini M, Montagnana M, Lippi G. Hepcidin and iron metabolism: from 
laboratory to clinical implications. Clinica chimica acta. 2010; 411:1565-9.  
 
29. Kroot JJC, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron 
disorders: Diagnostic implications. Clin Chem. 2011; 57:1650-69.  
 
30. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, 
Kahn A, Vaulont S. The gene encoding the iron regulatory peptide hepcidin is 
regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110:1037-
44.  
56 
 
 
 
31. Liu Q, Davidoff O, Niss K, Haase VH. Hypoxia-inducible factor regulates 
hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest. 2012; 122:4635-
44.  
 
32. Kwapisz J, Slomka A, Zekanowska E. Hepcidin and its role in iron homeostasis. J 
Int Fed Clin Chem.  
 
33. Rossi E. Hepcidin--the iron regulatory hormone. Clin Biochem Rev. 2005 Aug; 
26:47-9.  
 
34. Wrighting DM, Andrews NC. Interleukin induces hepcidin expression through 
STAT3. Blood. 2006; 108:3204-9.  
 
35. Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 
2004; 113:1251-3.  
 
36. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 
mediates hypoferremia of inflammation by inducing the synthesis of the iron 
regulatory hormone hepcidin. J Clin Invest. 2004; 113:1271-6.  
 
37. Robson KJ. Hepcidin and its role in iron absorption. Gut. 2004; 53:617-9.  
 
38. Beutler E. Hepcidin mimetics from microorganisms? A possible explanation for 
the effect of Helicobacter pylori on iron homeostasis. Blood Cells Mol Dis. 2007; 
38:54-5; discussion 6.  
 
39. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, 
MacFarlane J, Goldberg YP, Sakellaropoulos N, Ganz T, Nemeth E. Hepcidin in 
iron overload disorders. Blood. 2005; 105:4103-5.  
 
40. MacKenzie EL, Iwasaki K, Tsuji Y. Intracellular iron transport and storage: from 
molecular mechanisms to health implications. Antioxid Redox Signal. 2008; 
10:997-1030.  
 
41. Lill R, Hoffmann B, Molik S, Pierik AJ, Rietzschel N, Stehling O, Uzarska MA, 
Webert H, Wilbrecht C, Muhlenhoff U. The role of mitochondria in cellular iron-
sulfur protein biogenesis and iron metabolism. Biochimica et biophysica acta. 
2012; 1823:1491-508.  
 
42. Narahari J, Ma R, Wang M, Walden WE. The aconitase function of iron 
regulatory protein 1 - Genetic studies in yeast implicate its role in iron-mediated 
redox regulation. J Biol Chem. 2000; 275:16227-34.  
 
43. Garrick MD, Garrick LM. Cellular iron transport. Biochimica et biophysica acta. 
2009; 1790:309-25.  
 
57 
 
 
 
44. Le NTV, Richardson DR. The role of iron in cell cycle progression and the 
proliferation of neoplastic cells. Bba-Rev Cancer. 2002; 1603:31-46.  
 
45. Le NT, Richardson DR. The role of iron in cell cycle progression and the 
proliferation of neoplastic cells. Biochimica et biophysica acta. 2002; 1603:31-46.  
 
46. Seguin A, Ward DM, Kaplan J. Regulation of ribonucleotide reductase during 
iron limitation. Mol Cell. 2011; 44:683-4.  
 
47. Tong WH, Rouault TA. Metabolic regulation of citrate and iron by aconitases: 
role of iron-sulfur cluster biogenesis. Biometals. 2007; 20:549-64. 
 
48. Liu J, Chakraborty S, Hosseinzadeh P, Yu Y, Tian S, Petrik I, Bhagi A, Lu Y. 
Metalloproteins containing cytochrome, iron-sulfur, or copper redox centers. 
Chem Rev. 2014; 114:4366-469.  
 
49. Johnson DC, Dean DR, Smith AD, Johnson MK. Structure, function, and 
formation of biological iron-sulfur clusters. Annu Rev Biochem. 2005; 74:247-81.  
 
50. Miller JL. Iron deficiency anemia: a common and curable disease. Cold Spring 
Harb Perspect Med. 2013.  
 
51. WHO. Iron Deficiency Anemia Assessment Prevention and Control: A Guide for 
Program Managers. World Health Organization, Geneva, Switzerland; 2001.  
 
52. WHO/CDC. Worldwide Prevalence of Anaemia 1993-2005. WHO Global 
Database on Anaemia. Geneva, World Health Organization; 2008.  
 
53. WHO/FAO. Guidelines on Food Fortification with Micronutrients. Geneva, 
Switzerland; 2006.  
 
54. Hurrell R. Iron and malaria: absorption, efficacy and safety. Int J Vitam Nutr Res. 
2010; 80:279-92.  
 
55. Lynch SR. The impact of iron fortification on nutritional anaemia. Best Pract Res 
Clin Haematol. 2005; 18:333-46.  
 
56. Allen LH. Anemia and iron deficiency: effects on pregnancy outcome. Am J Clin 
Nutr. 2000; 71:1280S-4S.  
 
57. Steer PJ. Maternal hemoglobin concentration and birth weight. Am J Clin Nutr. 
2000; 71:1285S-7S.  
 
58 
 
 
 
58. Sekhavat L, Davar R, Hosseinidezoki S. Relationship between maternal 
hemoglobin concentration and neonatal birth weight. Hematology. 2011; 16:373-
6.  
 
59. Bondevik GT, Lie RT, Ulstein M, Kvale G. Maternal hematological status and 
risk of low birth weight and preterm delivery in Nepal. Acta Obstet Gynecol  
Scand. 2001;80:402-8.  
 
60. Mavalankar DV, Gray RH, Trivedi CR. Risk factors for preterm and term low 
birthweight in Ahmedabad, India. Int J Epidemiol. 1992; 21:263-72.  
 
61. Levy A, Fraser D, Katz M, Mazor M, Sheiner E. Maternal anemia during 
pregnancy is an independent risk factor for low birthweight and preterm delivery. 
Eur J Obstet Gynecol Reprod Biol. 2005; 122:182-6.   
 
62. Hulthén L. Iron deficiency and cognition. Food Nutr Res. 2003; 47.3: 152-156.  
 
63. Lozoff B, Jimenez F, Hagen J, Mollen E, Wolf AW. Poorer behavioral and 
developmental outcome more than 10 years after treatment for iron deficiency in 
infancy. Pediatrics. 2000; 105:E51.  
 
64. Carter RC, Jacobson JL, Burden MJ, Armony-Sivan R, Dodge NC, Angelilli ML, 
Lozoff B, Jacobson SW. Iron deficiency anemia and cognitive function in 
infancy. Pediatrics. 2010; 126:e427-34.  
 
65. Batra J, Sood A. Iron deficiency anaemia: Effect on congnitive development in 
children: A review. Indian J Clin Biochem. 2005; 20:119-25.  
 
66. Youdim MB, Green AR. Iron deficiency and neurotransmitter synthesis and 
function. Proc Nutr Soc. 1978; 37:173-9.  
 
67. Gardner GW, Edgerton VR, Senewiratne B, Barnard RJ, Ohira Y. Physical work 
capacity and metabolic stress in subjects with iron deficiency anemia. Am J Clin 
Nutr. 1977; 30:910-7.  
 
68. Edgerton VR, Ohira Y, Hettiarachchi J, Senewiratne B, Gardner GW, Barnard RJ. 
Elevation of hemoglobin and work tolerance in iron-deficient subjects. J Nutr Sci 
Vitaminol. 1981; 27:77-86.  
 
69. Ohira Y, Edgerton VR, Gardner GW, Senewiratne B, Barnard RJ, Simpson DR. 
Work capacity, heart rate and blood lactate responses to iron treatment. Br J 
Haematol. 1979; 41:365-72.  
 
59 
 
 
 
70. Haas JD, Brownlie Tt. Iron deficiency and reduced work capacity: a critical 
review of the research to determine a causal relationship. J Nutr. 2001; 131:676S-
88S; discussion 88S-90S.  
 
71. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. 
Clin J Am Soc Nephrol. 2006; 1 Suppl 1:S4-8.  
 
72. Cogswell ME, Looker AC, Pfeiffer CM, Cook JD, Lacher DA, Beard JL, Lynch 
SR, Grummer-Strawn LM. Assessment of iron deficiency in US preschool 
children and nonpregnant females of childbearing age: National Health and 
Nutrition Examination Survey 2003-2006. Am J Clin Nutr. 2009; 89:1334-42.  
 
73. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of 
iron deficiency in the United States. JAMA. 1997; 277:973-6.  
 
74. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative 
measure of tissue iron deficiency. Blood. 1990; 75:1870-6.  
 
75. Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, Font F, Acosta CJ, 
Schellenberg DM, Galindo CM, Kimario J, et al. Randomised placebo-controlled 
trial of iron supplementation and malaria chemoprophylaxis for prevention of 
severe anaemia and malaria in Tanzanian infants. Lancet. 1997; 350:844-50.  
 
76. Preziosi P, Prual A, Galan P, Daouda H, Boureima H, Hercberg S. Effect of iron 
supplementation on the iron status of pregnant women: consequences for 
newborns. Am J Clin Nutr. 1997; 66:1178-82. 
 
77. Berglund SK, Westrup B, Hagglof B, Hernell O, Domellof M. Effects of iron 
supplementation of LBW infants on cognition and behavior at 3 years. Pediatrics. 
2013; 131:47-55.  
 
78. Cogswell ME, Parvanta I, Ickes L, Yip R, Brittenham GM. Iron supplementation 
during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J 
Clin Nutr. 2003; 78:773-81.  
 
79. Meier PR, Nickerson HJ, Olson KA, Berg RL, Meyer JA. Prevention of iron 
deficiency anemia in adolescent and adult pregnancies. Clin Med Res. 2003; 1:29-
36.  
 
80. WHO. Guideline: Intermittent Iron Supplementation in Preschool and School-Age 
Children. Geneva, Switzerland; 2011.  
 
81. Stoltzfus R, Dreyfuss M. Guidelines for the Use of Iron Supplements to Prevent 
and Treat Iron Deficiency Anaemia. The International Nutritional Anaemia 
Consultative Group (INACG), the World Health Organization, and the United 
Nations Children’s Fund, Washington, D.C; 1998.  
60 
 
 
 
82. Haldar K, Mohandas N. Malaria, erythrocytic infection, and anemia. Hematology 
Am Soc Hematol Educ Program. 2009:87-93.  
 
83. Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra 
U, Kabole I, Deb S, Othman MK, et al. Effects of routine prophylactic 
supplementation with iron and folic acid on admission to hospital and mortality in 
preschool children in a high malaria transmission setting: community-based, 
randomised, placebo-controlled trial. Lancet. 2006; 367:133-43.  
 
84. Ojukwu JU, Okebe JU, Yahav D, Paul M. Oral iron supplementation for 
preventing or treating anaemia among children in malaria-endemic areas. 
Cochrane Database Syst Rev. 2009:CD006589.  
 
85. Thuy PV, Berger J, Davidsson L, Khan NC, Lam NT, Cook JD, Hurrell RF, Khoi 
HH. Regular consumption of NaFeEDTA-fortified fish sauce improves iron status 
and reduces the prevalence of anemia in anemic Vietnamese women. Am J Clin 
Nutr. 2003; 78:284-90. 
 
86. Ballot DE, MacPhail AP, Bothwell TH, Gillooly M, Mayet FG. Fortification of 
curry powder with NaFe(111)EDTA in an iron-deficient population: initial survey 
of iron status. Am J Clin Nutr. 1989; 49:156-61.  
 
87. Sari M, Bloem MW, de Pee S, Schultink WJ, Sastroamidjojo S. Effect of iron-
fortified candies on the iron status of children aged 4-6 y in East Jakarta, 
Indonesia. Am J Clin Nutr. 2001; 73:1034-9.  
 
88. Viteri FE, Alvarez E, Batres R, Torun B, Pineda O, Mejia LA, Sylvi J. 
Fortification of sugar with iron sodium ethylenediaminotetraacetate (FeNaEDTA) 
improves iron status in semirural Guatemalan populations. Am J Clin Nutr. 1995; 
61:1153-63. 
 
89. Haas JD, Beard JL, Murray-Kolb LE, del Mundo AM, Felix A, Gregorio GB. 
Iron-biofortified rice improves the iron stores of nonanemic Filipino women. J 
Nutr. 2005; 135:2823-30.  
 
90. Kodkany BS, Bellad RM, Mahantshetti NS, Westcott JE, Krebs NF, Kemp JF, 
Hambidge KM. Biofortification of pearl millet with iron and zinc in a randomized 
controlled trial increases absorption of these minerals above physiologic 
requirements in young children. J Nutr. 2013; 143:1489-93.  
 
91. Poletti S, Gruissem W, Sautter C. The nutritional fortification of cereals. Curr 
Opin Biotech. 2004; 15:162-5.  
 
92. Nestel P, Bouis HE, Meenakshi JV, Pfeiffer W. Biofortification of staple food 
crops. J Nutr. 2006; 136:1064-7.  
 
61 
 
 
 
93. Ahluwalia N. Intervention strategies for improving iron status of young children 
and adolescents in India. Nutr Rev. 2002; 60:S115-7.  
 
94. Patterson AJ, Brown WJ, Roberts DC, Seldon MR. Dietary treatment of iron 
deficiency in women of childbearing age. Am J Clin Nutr. 2001; 74:650-6.  
 
95. Verrall T, Gray-Donald K. Impact of a food-based approach to improve iron 
nutrition of at-risk infants in northern Canada. Prev Med. 2005; 40:896-903.  
 
96. Thompson B, Food-based approaches for combating iron deficiency. In 
Combating Micronutrient Deficiencies: Food-based Approaches.  Thompson B, 
Amoroso, L., Editor. FAO and CABI: Rome; 2011.   
 
97. Zimmermann MB, Chaouki N, Hurrell RF. Iron deficiency due to consumption of 
a habitual diet low in bioavailable iron: a longitudinal cohort study in Moroccan 
children. Am J Clin Nutr. 2005; 81:115-21.  
 
98. Gleerup A, Rossander-Hulthen L, Gramatkovski E, Hallberg L. Iron absorption 
from the whole diet: comparison of the effect of two different distributions of 
daily calcium intake. Am J Clin Nutr. 1995; 61:97-104.   
 
99. Institute of Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient 
Requirements. Washington DC: National Academies Press; 2006.  
 
100. Carriquiry AL. Assessing the prevalence of nutrient inadequacy. Public Health 
Nutr. 1999; 2:23-33.  
 
101. de Lauzon B, Volatier JL, Martin A. A Monte Carlo simulation to validate the 
EAR cut-point method for assessing the prevalence of nutrient inadequacy at the 
population level. Public Health Nutr. 2004; 7:893-900.  
 
102. Nusser SM, Carriquiry AL, Dodd KW, Fuller WA. A semiparametric 
transformation approach to estimating usual daily intake distributions. J Am Stat 
Assoc. 1996; 91:1440-9.  
 
103. Nusser SM, Battese GE, Fuller, WA. Method-of-moments estimation of usual 
nutrient Intakes distributions. CARD Working paper 90, Iowa State University; 
1990.  
 
104. National Research Council. Nutrient Adequacy: Assessment Using Food 
Consumption Surveys. Washington, DC: National Academies Press; 1986.  
 
105. Carriquiry AL. Estimation of usual intake distributions of nutrients and foods. J 
Nutr. 2003; 133:601s-8s.  
 
62 
 
 
 
106. Tooze JA, Kipnis V, Buckman DW, Carroll RJ, Freedman LS, Guenther PM, 
Krebs-Smith SM, Subar AF, Dodd KW. A mixed-effects model approach for 
estimating the distribution of usual intake of nutrients: the NCI method. Statist 
Med. 2010; 29:2857-68.  
 
107. Beaton GH. Uses and Limits of the Use of the Recommended Dietary-
Allowances for Evaluating Dietary-Intake Data. Am J Clin Nutr. 1985; 41:155-
64.  
 
108. Monsen ER, Hallberg L, Layrisse M, Hegsted DM, Cook JD, Mertz W, Finch 
CA. Estimation of available dietary iron. Am J Clin Nutr. 1978;31(1):134-41.  
 
109. Lykkesfeldt J, Michels AJ, Frei B. Vitamin C. Adv Nutr. 2014; 5:16-8.  
 
110. Hacisevkd A. An overview of ascorbic acid biochemistry. J Fac Pharm. 2009; 
38:233-55.  
 
111. Naidu KA. Vitamin C in human health and disease is still a mystery? An 
overview. Nutr J. 2003; 21:2-7.  
 
112. Lynch SR, Cook JD. Interaction of vitamin C and iron. Ann N Y Acad Sci. 1980; 
355:32-44.  
 
113. Rossander L, Hallberg L, Bjorn-Rasmussen E. Absorption of iron from breakfast 
meals. Am J Clin Nutr. 1979; 32:2484-9.  
 
114. Kuhn IN, Roche M, Layrisse M, Martinez C, Walker RB. Observations on the 
mechanism of iron absorption. Am J Clin Nutr. 1968; 21:1184-8.  
 
115. Callender ST, Marney SR, Jr., Warner GT. Eggs and iron absorption. Br J 
Haematol. 1970; 19:657-65.  
 
116. Layrisse M, Martinez-Torress C, Gonzalez M. Measurement of the total daily 
dietary iron absorption by the extrinsic tag model. Am J Clin Nutr. 1974; 27:152-
62.  
 
117. Cook JD, Monsen ER. Vitamin C, the common cold, and iron absorption. Am J 
Clin Nutr. 1977; 30:235-41.  
 
118. Hallberg L, Brune M, Rossander L. Iron-absorption in man - Ascorbic-acid and 
dose-dependent inhibition by phytate. Am J Clin Nutr. 1989; 49:140-4.  
 
119. Siegenberg D, Baynes RD, Bothwell TH, Macfarlane BJ, Lamparelli RD, Car 
NG, Macphail P, Schmidt U, Tal A, Mayet F. Ascorbic-acid prevents the dose-
63 
 
 
 
dependent Inhibitory effects of polyphenols and phytates on nonheme-iron 
absorption. Am J Clin Nutr. 1991; 53:537-41.  
 
120. Teucher B, Olivares M, Cori H. Enhancers of iron absorption: Ascorbic acid and 
other organic acids. Int J Vitam Nutr Res. 2004; 74:403-19.  
 
121. Baech SB, Hansen M, Bukhave K, Jensen M, Sorensen SS, Kristensen L, 
Purslow PP, Skibsted LH, Sandstrom B. Nonheme-iron absorption from a 
phytate-rich meal is increased by the addition of small amounts of pork meat. Am 
J Clin Nutr. 2003; 77:173-9.  
 
122. Hallberg L, Hoppe M, Andersson M, Hulthen L. The role of meat to improve the 
critical iron balance during weaning. Pediatrics. 2003; 111:864-70.  
 
123. Hallberg L, Rossander L. Improvement of iron nutrition in developing countries: 
comparison of adding meat, soy protein, ascorbic acid, citric acid, and ferrous 
sulphate on iron absorption from a simple Latin American-type of meal. Am J 
Clin Nutr. 1984; 39:577-83.  
 
124. Cook JD, Brown GM, Valberg LS. The effect of achylia gastrica on iron 
absorption. J Clin Invest. 1964; 43:1185-91.  
 
125. Hurrell RF, Reddy MB, Juillerat M, Cook JD. Meat protein fractions enhance 
nonheme iron absorption in humans. J Nutr. 2006; 136:2808-12.  
 
126. Bohn L, Meyer AS, Rasmussen SK. Phytate: impact on environment and human 
nutrition. A challenge for molecular breeding. J Zhejiang Univ Sci B. 2008; 
9:165-91.  
 
127. Brown KH, Rivera JA, Bhutta Z, Gibson RS, King JC, Lonnerdal B, Ruel MT, 
Sandtrom B, Wasantwisut E, Hotz C. International Zinc Nutrition Consultative 
Group (IZiNCG) technical document #1. Assessment of the risk of zinc 
deficiency in populations and options for its control. Food Nutr Bull. 2004; 
25:S99-203.  
 
128. Minihane AM, Rimbach G. Iron absorption and the iron binding and anti-oxidant 
properties of phytic acid. Int J Food Sci Tech. 2002; 37:741-8.  
 
129. Amirabdollahian F, Ash R. An estimate of phytate intake and molar ratio of 
phytate to zinc in the diet of the people in the United Kingdom. Public Health 
Nutr. 2010; 13:1380-8.  
 
130. Harland BF, Peterson M. Nutritional status of lacto-ovo vegetarian Trappist 
monks. J Am Diet Assoc. 1978; 72:259-64.  
 
64 
 
 
 
131. Sandberg AS, Brune M, Carlsson NG, Hallberg L, Skoglund E, Rossander-
Hulthen L. Inositol phosphates with different numbers of phosphate groups 
influence iron absorption in humans. Am J Clin Nutr. 1999; 70:240-6.  
 
132. Sandberg AS, Carlsson NG, Svanberg U. Effects of inositol triphosphates, 
tetraphosphates, pentaphosphates, and hexaphosphates on invitro estimation of 
iron availability. J Food Sci. 1989; 54:159-61.  
 
133. Hallberg L, Brune M, Rossander L. Iron absorption in man: ascorbic acid and 
dose-dependent inhibition by phytate. Am J Clin Nutr. 1989; 49:140-4.  
 
134. Hurrell RF, Juillerat MA, Reddy MB, Lynch SR, Dassenko SA, Cook JD. Soy 
protein, phytate, and iron absorption in humans. Am J Clin Nutr. 1992; 56:573-8. 
 
135. Gibson RS, Yeudall F, Drost N, Mtitimuni B, Cullinan T. Dietary interventions 
to prevent zinc deficiency. Am J Clin Nutr. 1998; 68:484s-7s.  
 
136. Tsao R. Chemistry and biochemistry of dietary polyphenols. Nutrients. 2010; 
2:1231-46.  
 
137. Scalbert A, Johnson IT, Saltmarsh M. Polyphenols: antioxidants and beyond. Am 
J Clin Nutr. 2005; 81:215s-7s.  
 
138. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food 
sources and bioavailability. Am J Clin Nutr. 2004; 79:727-47.  
 
139. Madaan K, Lather V, Pandita D. Evaluation of polyamidoamine dendrimers as 
potential carriers for quercetin, a versatile flavonoid. Drug Deliv. 2014; 20:1-9. 
 
140. Hallberg L, Hulthen L. Prediction of dietary iron absorption: an algorithm for 
calculating absorption and bioavailability of dietary iron. AM J Clin Nutr. 2000; 
71:1147-60.  
 
141. Hurrell RF, Reddy M, Cook JD. Inhibition of non-haem iron absorption in man 
by polyphenolic-containing beverages. Br J Nutr. 1999; 81:289-95.  
 
142. Brune M, Rossander L, Hallberg L. Iron absorption and phenolic compounds: 
importance of different phenolic structures. Eur J Clin Nutr. 1989; 43:547-57.  
 
143. Disler PB, Lynch SR, Charlton RW, Torrance JD, Bothwell TH, Walker RB, 
Mayet F. The effect of tea on iron absorption. Gut. 1975; 16:193-200.  
 
144. Zijp IM, Korver O, Tijburg LB. Effect of tea and other dietary factors on iron 
absorption. Crit Rev Food Sci Nutr. 2000; 40:371-98.  
 
65 
 
 
 
145. Tuntawiroon M, Sritongkul N, Brune M, Rossander-Hulten L, Pleehachinda R, 
Suwanik R, Hallberg L. Dose-dependent inhibitory effect of phenolic compounds 
in foods on nonheme-iron absorption in men. Am J Clin Nutr 1991; 53:554-7. 
 
146. South PK, House WA, Miller DD. Tea consumption does not affect iron 
absorption in rats unless tea and iron are consumed together. Nutr Res. 1997; 
17:1303-10.  
 
147. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 
2010; 5 Suppl 1:S23-30.  
 
148. Deehr MS, Dallal GE, Smith KT, Taulbee JD, Dawsonhughes B. Effects of 
different calcium sources on iron-absorption in postmenopausal women. Am J 
Clin Nutr. 1990; 51:95-9.  
 
149. Cook JD, Dassenko SA, Whittaker P. Calcium supplementation - Effect on iron-
absorption. Am J Clin Nutr. 1991; 53:106-11.  
 
150. Hallberg L. Does calcium interfere with iron absorption? Am J Clin Nutr. 1998; 
68:3-4.  
 
151. Hallberg L, Brune M, Erlandsson M, Sandberg AS, Rossanderhulten L. Calcium 
- Effect of different amounts on nonheme-iron and heme-iron absorption in 
humans. Am J Clin Nutr. 1991; 53:112-9.  
 
152. Wienk KJ, Marx JJ, Beynen AC. The concept of iron bioavailability and its 
assessment. Eur J Nutr. 1999; 38:51-75.  
 
153. Au AP, Reddy MB. Caco-2 cells can be used to assess human iron 
bioavailability from a semipurified meal. J Nutr. 2000; 130:1329-34.  
 
154. Kapsokefalou M, Miller DD. Effects of meat and selected food components on 
the valence of nonheme iron during invitro digestion. J Food Sci. 1991; 56:352-
55.  
 
155. Kapsokefalou M, Alexandropoulou I, Komaitis M, Politis I. In vitro evaluation 
of iron solubility and dialyzability of various iron fortificants and of iron-fortified 
milk products targeted for infants and toddlers. Int J Food Sci Nutr. 2005; 56:293-
302.  
 
156. Wolfgor R, Drago SR, Rodriguez V, Pellegrino NR, Valencia ME. In vitro 
measurement of available iron in fortified foods. Food Res Int. 2002; 35:85-90.  
 
157. Yun SM, Habicht JP, Miller DD, Glahn RP. An in vitro digestion/Caco-2 cell 
culture system accurately predicts the effects of ascorbic acid and polyphenolic 
compounds on iron bioavailability in humans. J Nutr. 2004; 134:2717-21.  
66 
 
 
 
158. Forbes AL, Arnaud MJ, Chichester CO, Cook JD, Harrison BN, Hurrell RF, 
Kahn SG, Morris ER, Tanner JT, Whittaker P, et al. Comparison of in vitro, 
animal, and clinical determinations of iron bioavailability: International 
Nutritional Anemia Consultative Group Task Force report on iron bioavailability. 
Am J Clin Nutr. 1989; 49:225-38.  
 
159. Swain JH, Newman SM, Hunt JR. Bioavailability of elemental iron powders to 
rats is less than bakery-grade ferrous sulfate and predicted by iron solubility and 
particle surface area. J Nutr. 2003; 133:3546-52.  
 
160. Wegmuller R, Zimmermann MB, Moretti D, Arnold M, Langhans W, Hurrell 
RF. Particle size reduction and encapsulation affect the bioavailability of ferric 
pyrophosphate in rats. J Nutr. 2004; 134:3301-4.  
 
161. Miller J, McNeal LS. Bioavailability of egg yolk iron measured by hemoglobin 
regeneration in anemic rats. J Nutr. 1983; 113:115-23.  
 
162. Howard L, Buchowski M, Wang BJ, Miller DD. Bioavailability of electrolytic 
iron in fortified infant cereal determined by hemoglobin repletion in piglets. Nutr 
Res. 1993; 13:287-95.  
 
163. Cook JD, Layrisse M, Martinez-Torres C, Walker R, Monsen E, Finch CA. Food 
iron absorption measured by an extrinsic tag. J Clin Invest. 1972; 51:805-15.  
 
164. Benito P, Miller D. Iron absorption and bioavailability: An updated review. Nutr 
Res. 1998; 18:581-603.  
 
165. Conway RE, Geissler CA, Hider RC, Thompson RP, Powell JJ. Serum iron 
curves can be used to estimate dietary iron bioavailability in humans. J Nutr. 
2006; 136:1910-4. 
 
166. Monsen ER, Balintfy JL. Calculating dietary iron bioavailability: refinement and 
computerization. J Am Diet Assoc. 1982; 80:307-11.  
 
167. Tseng M, Chakraborty H, Robinson DT, Mendez M, Kohlmeier L. Adjustment 
of iron intake for dietary enhancers and inhibitors in population studies: 
bioavailable iron in rural and urban residing Russian women and children. J Nutr. 
1997; 127:1456-68.  
 
168. Conway RE, Powell JJ, Geissler CA. A food-group based algorithm to predict 
non-heme iron absorption. Int J Food Sci Nutr. 2007; 58:29-41.  
 
169. Bhargava A, Bouis HE, Scrimshaw NS. Dietary intakes and socioeconomic 
factors are associated with the hemoglobin concentration of Bangladeshi women. 
J Nutr. 2001; 131:758-64.  
 
67 
 
 
 
170. Rickard AP, Chatfield MD, Conway RE, Stephen AM, Powell JJ. An algorithm 
to assess intestinal iron availability for use in dietary surveys. Br J Nutr. 2009; 
102:1678-85.  
 
171. Beard JL, Murray-Kolb LE, Haas JD, Lawrence F. Iron absorption prediction 
equations lack agreement and underestimate iron absorption. J Nutr. 2007; 
137:1741-6.  
 
172. Hunt JR, Gallagher SK, Johnson LK. Effect of ascorbic acid on apparent iron 
absorption by women with low iron stores. Am J Clin Nutr. 1994; 59:1381-5.  
 
173. Cook JD, Reddy MB. Effect of ascorbic acid intake on nonheme-iron absorption 
from a complete diet. Am J Clin Nutr. 2001; 73:93-8. 
 
 
 
 
 
 
 
 
 
   
68 
 
 
 
CHAPTER 3. A COMPLETE DIET BASED ALGORITHM FOR PREDICTING 
NONHEME IRON ABSORPTION IN ADULTS 
Modified from a paper published in Journal of Nutrition1. 
Seth M Armah2,3, Alicia Carriquiry4, Debra Sullivan5, James D. Cook6, Manju B Reddy2,7 
Abstract 
Many algorithms have been developed in the past few decades to estimate 
nonheme iron absorption from the diet based on single meal absorption studies. Yet, 
single meal studies exaggerate the effect of diet and other factors on absorption. Here, we 
propose a new algorithm based on complete diets for estimating nonheme iron 
absorption. We used data from four complete diet studies each with 12-14 subjects, for a 
total of 53 subjects (19 males and 34 females) aged 19-38 y. In each study, each subject 
was observed over three one-week periods during which they consumed different diets. 
The diets were typical, high or low in meat, tea, calcium or vitamin C intakes.  The total 
sample size was 159 (53 X 3) observations.  We used multiple linear regression to 
quantify the effect of different factors on iron absorption. Serum ferritin was the most 
important factor in explaining differences in nonheme iron absorption, whereas the effect 
of dietary factors was small. When our algorithm was validated with single meal and 
complete diet data, the respective R2 values were 0.57; P<0.001 and 0.84; P< 0.0001. 
Results also suggest that between-person variations explain a large proportion of the 
                                                          
1 Published in Journal of Nutrition, 2013, 143 (7):1136-40. 
2 Department of Food Science and Human Nutrition, Iowa State University.  
3 Primary author. 
4 Department of Statistics, Iowa State University. Involved in project design and manuscript preparation. 
5 Department of Dietetics and Nutrition, University of Kansas Medical Center. Was responsible for    
estimating phytate content. 
6 Department of Hematology/Oncology, University of Kansas Medical Center. Involved in design of the 
human studies and a co-author of the human studies data that were used for developing algorithm. 
7 Corresponding author. Involved in design of the project and manuscript preparation. 
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differences in nonheme iron absorption. The algorithm based on complete diets we 
propose is useful for predicting nonheme iron absorption from the diets of different 
populations. 
Introduction 
Iron deficiency anemia is a leading global problem mostly attributed to low 
intakes of dietary iron and also poor iron bioavailability. Efforts to explore the 
relationship among iron intake, bioavailability, absorption and status, have led to the 
development of several algorithms to predict iron absorption in the past few decades. 
These have been reviewed by Reddy (1) and also more recently a new algorithm was 
published by Rickard et al. (2). A major limitation of the published algorithms is that they 
were developed based on single meal absorption studies (2-4). It is well known that the 
effect of dietary factors on iron bioavailability is exaggerated in single meal studies (5).  
For example, when iron absorption was measured from a 5-d complete diet, the effect of 
meat, calcium and ascorbic acid were diminished (6-8). In a human study, Hunt and 
Roughead (9) reported a decrease in nonheme iron absorption among men consuming 
high bioavailability diets and an increase among those on low bioavailability diet after 10 
wk of feeding suggesting that individuals adapt to the effect of dietary factors on iron 
absorption. Although vitamin C is known to increase iron absorption from single meal 
feeding studies, 2 g/d vitamin C supplementation for 16 wk had no effect on iron stores 
(10). The above studies suggest that the effect of dietary factors on iron absorption is 
dampened with longer periods of consumption, and that there is the possibility that 
adaptation may occur over prolonged exposure to iron inhibitors or enhancers. Hence, the 
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lack of agreement between predicted absorption from existing algorithms and iron 
absorption measured from whole diets and long-term studies is not unexpected (11, 12).  
Predicting iron absorption from a complete or whole diet thus requires an 
algorithm that is developed from a complete diet. The complete diet here refers to a 
person’s total daily intake estimated from one or more days. Studies have been conducted 
to examine the effect of different dietary factors on iron absorption from a complete diet 
consumed over a 5-d period (6-8) and unpublished data). Detailed nutrient intakes and 
absorption measurements have been published from these studies.  In each of these 
studies, participants consumed three different diets, each during a period of five days.  
The diets included in the studies were a typical diet and two modified diets with low and 
high levels of the factor tested in the particular study. The four dietary factors that were 
included in three different levels in the four studies were tea, meat, vitamin C and 
calcium. By combining data from these studies we can approximately recreate the 
heterogeneity of typical diets consumed by various populations. The objective of this 
study was therefore to develop a new algorithm based on complete diet data from these 
studies, which will be useful in assessing iron absorption in populations.  
Methods 
Data Description. We used data from four different studies that were designed to 
measure nonheme iron absorption from a 5-d complete diet using extrinsic radio iron 
labeling technique (6-8) and unpublished data). Each study included 12-14 subjects (19 
males and 34 females) aged 19-38 y, with a total of 53 subjects. All subjects were healthy 
with no history of disorders known to affect iron absorption. The studies were designed 
to determine the effects of ascorbic acid, meat, tea and calcium on nonheme iron 
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absorption from a complete diet. Each subject consumed diets with low, typical and high 
levels of the dietary factors being studied (ascorbic acid, tea, meat or calcium). 
Absorption of nonheme iron was measured for each dietary period using extrinsic 
radiolabeling technique by labeling each of the three main meals of the day for 5 d and 
snacking in between meals was not allowed, except for the calcium study where 
preliminary data indicated that most subjects consumed two main meals, thus only the 
two main meals were labeled (7). Even with the snack consumption, the effect would be 
very small on iron absorption since they were not taken together with the meals. Each 
study reported mean daily nutrient intake during the labeling period, iron status (baseline 
serum ferritin) and percent iron absorption. Dietary records were kept by subjects and 
nutrient intakes were determined using the NUTRITIONIST IV program (N-squared 
Computing, First Data Bank Division, Hearst Corporation, San Bruno, CA). Phytic acid 
was not reported in those studies, however, we determined the phytic acid content using 
the Nutrition Data System for Research (University of Minnesota Nutrition Coordinating 
Center) since we had access to the complete dietary data.    Tea consumption was 
estimated using black tea equivalents as follows: 2 cups (480mL) of iced tea and 1.5 cups 
(360mL) of herbal tea or coffee were coded as 1 cup (240mL) of black tea (13). One cup 
(240ml) of black tea equals I tea bag (1.9g of black tea). Other details about data 
collection procedures have been described elsewhere (8). Data collection procedure for 
the tea study (unpublished data) was similar to those described above and was approved 
by the Human Subjects Committee at the Kansas University Medical Center. Since each 
respondent had three data points for high, low and typical intake of the specified factor, 
the total number of observations in the combined data was 159. 
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Data Analysis. We used R software version 2.12.2 to carry out the data analysis. 
The factors we considered in the analysis were serum ferritin, calcium, phytic acid, 
ascorbic acid, tea, nonheme iron, and meat, fish and poultry (MFP). We transformed all 
variables using a log transformation to better approximate normality. To develop the 
algorithm, we fitted a linear multiple regression model using the above factors to predict 
percent iron absorption. We included a person-level random effect in the model because 
each individual contributed three different observations and this induces intra-class 
correlation. We obtained maximum likelihood estimates of fixed effects and variance 
components (the latter based on a restricted likelihood function) and best linear unbiased 
predictors of the person-level effects. P-values were considered significant if P< 0.05, 
and weakly significant if 0.05 < P < 0.1. We reported the median (10th, 90th percentiles) 
for the dietary factors and the geometric mean (10th, 90th percentile) for serum ferritin and 
absorption to avoid the influence of extreme values since the data are not normally 
distributed. 
Validation of algorithm with human iron absorption data. We assessed the 
validity of the algorithm by estimating absorption using dietary intake and serum ferritin 
data from different published studies (both single meals and complete diets), and 
comparing results with reported absorption values. The single meal study included mean 
values for nutrient intakes and absorption from 19 different meals (4) which was 
designed to measure nonheme iron absorption from single meals fed after an overnight 
fast. Similarly we validated our algorithm separately using data from published complete 
diet studies (9, 14-17). The data from these studies were the mean values for dietary 
intakes, initial serum ferritin concentration, and unadjusted absorption for different arms 
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of each study (n=23).  In cases where the mean ferritin values were not given for the 
different arms, we used the mean for the whole group for each arm. In some of the data 
from the study by Tetens et al. (15) the quantity of tea consumed was not reported. We 
therefore assumed one cup if tea was included in the meal and validation was done with 
and without those data points.  
Results 
Serum ferritin concentration ranged from 5 to 162 µg/L (n=53), with geometric 
mean of 41.2 µg/L when all studies (6-8) and unpublished data) were combined. Since 
each of the 53 subjects consumed three different diets in the various studies, the dietary 
intakes presented in Table 1 gives the median (10th, 90th percentiles) of the different 
factors by diet type and for all diets put together.  
Results from the mixed effects model (Table 2) suggest that between-person 
differences explain a large proportion of the variation in nonheme iron absorption. This is 
reflected by the equal variances for the residual and the grouping variable (ID) for the 
random effect. Although the dietary factors had minimal contribution in explaining 
variations in absorption, their inhibitory or enhancing effect was as expected. However, 
serum ferritin had a highly significant effect on absorption (P < 0.0001), explaining 
approximately 35 % of the variance in absorption as shown under the partial R2 column. 
The residual plot (Figure 1A) shows no pattern when we plot standardized residual 
against the fitted values and there is good correlation between observed and fitted 
absorption (Figure 1B) suggesting that the model fits the data well. The fitted regression 
model is: 
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Ln Absorption (%) = 6.294 - 0.709 ln (SF) + 0.119 ln (C) + 0.006 ln (MFP+0.1) 
- 0.055 ln (T+0.1) - 0.247 ln (P) - 0.137 ln (Ca) - 0.083 ln (NH) 
where SF is Serum ferritin (µg/L), C is vitamin C (mg), MFP is meat, fish and poultry 
(g), T is tea (number of cups), P is Phytate (mg), Ca is calcium (mg) and NH is nonheme 
iron (mg). 
Validation of model for predicting nonheme iron absorption. We observed a 
significant positive correlation (R2=0.57; P < 0.001; Figure 2A) when we fitted the 
proposed model to predict nonheme iron absorption from the single meal study that 
reported mean values for 19 meals (4). Similarly, we found a significant correlation 
(R2=0.84, P < 0.0001; Figure 2B) between predicted absorption and measured absorption 
from complete diets data. The R2 did not change (R2 = 0.84) when we excluded the data 
points from the Tetens et al. (15) study that did not have the quantity of tea consumed. 
Discussion 
The magnitude of the global problem of anemia makes it important to determine 
means of estimating the percentage of iron absorbed, particularly from nonheme sources, 
since they provide the main sources of iron in many developing countries. Accurately 
estimating iron absorption is also essential to set dietary recommendations. Since iron 
absorption from single meals exaggerates the effect of dietary factors (5, 9, 12), there is 
concern about the use of algorithms based on single meals to estimate iron absorption 
from a whole diet. By overestimating absorption, we risk underestimating the prevalence 
of inadequate iron intakes.  This is one reason why development of an algorithm based on 
complete diets that can accurately predict iron absorption is critical.  
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The algorithm we propose was developed from complete diet data sets that 
include a wide range of intake of the dietary factors known to affect nonheme iron 
absorption, and therefore should reflect the consumption pattern of many populations. 
Maximum intakes for most dietary factors were extremely high due to the designs of the 
studies from which the data were obtained. For example, the maximum intake of vitamin 
C was 584 mg which far exceeds the usual intake in most populations. Similarly the very 
low minimum intakes make the algorithm useful for populations with extremely low 
intakes of these dietary factors. For instance, the model can be used to estimate iron 
absorption among vegetarians and among people who do not consume tea or coffee 
habitually. Besides, tea estimation in our study as number of cups (in black tea 
equivalents) is much easier than estimating polyphenols content since inaccuracies exist 
in estimating different types of polyphenols.  
Most of the existing algorithms require estimating iron absorption from each meal 
separately to obtain total daily iron absorption (3, 4, 18). When wide ranges of total daily 
nutrient intakes are used with singles meal algorithms the result may be inaccurate. For 
instance, when we predicted nonheme iron absorption from the published complete diet 
data sets (9, 14-17) using the Reddy et al. (4) and the Hallberg and Hulthén (3) 
algorithms, some of the predicted absorption values for both algorithms were above 100 
% due to the wide ranges of intakes used. A similar observation was made by Rickard et 
al. (2) and Beard et al. (12). However, with our proposed algorithm, total daily nutrient 
intakes may be used without the need to calculate bioavailability for individual meals. In 
addition, this algorithm incorporates iron status (serum ferritin) in the model unlike 
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previous algorithms. Including serum ferritin in the model avoids any errors that can arise 
when adjusting for serum ferritin using another equation.    
Of the different factors considered in this algorithm, serum ferritin had the 
strongest effect in the model. It was not surprising to see that the effect of dietary factors 
was minimal, because even with a single meal study in which dietary factors were 
accurately measured in the laboratory, only 16 % of variation in absorption was explained 
by dietary factors after adjusting for serum ferritin (4)  . Cook et al. (5) have also shown 
that in the whole diet the effect of dietary factors is dampened, supporting our findings. 
Among the dietary factors, only phytic acid was weakly significant in the model (P = 
0.09).While we expect minimal effect of these dietary factors as indicated by the 
literature, it is also possible that phytic acid was weakly significant because it is mostly a 
component of the iron containing meal and can therefore chelate nonheme iron to reduce 
its bioavailability. Including higher forms of inositol phosphates (hexa and penta 
inositols) could give a better model, however these are rarely found in food composition 
databases compared to total phytate. Since the aim of our study was to provide more 
convenient model for use in population studies rather than one that requires laboratory 
analysis of foods, total phytate content was used in developing the model.   
Although polyphenols have strong inhibitory effect on iron absorption, they didn’t 
show much effect on our model.  While it would have been more appropriate to use 
polyphenol content instead of black tea equivalents that would make the model more 
demanding to use because foods/beverages have different forms of polyphenols. Besides 
there are different methods for measuring polyphenols and the results differ from method 
to method. Studies have reported polyphenols content as gallic acid or catechin 
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equivalents. To avoid difficulties related to type and method of polyphenols analysis we 
included in the manuscript conversion factor for different beverages to black tea 
equivalents. The conversion factors take into account the polyphenol contents of the 
different beverages and are easy to use in the population studies. Based on previous 
studies showing the effect of different types of beverages on iron absorption (13), it is 
reasonable to estimate polyphenols using black tea equivalents rather than absolute 
amounts. One cup of black tea contains 200-250 mg catechin equivalents.  
Other factors such as tea, calcium and ascorbic acid may not necessarily be 
consumed together with the meals. For example Morck et al. (19) and South et al. (20) 
have shown that tea had to be consumed with the meal to inhibit iron absorption. Also 
dairy products as sources of calcium may be consumed separate from the meal, thus 
minimizing their effect on nonheme iron absorption (21). The results of this study support 
the findings by Reddy et al. (6) that the contribution of heme iron by MFP is more 
important in improving iron status than in promoting nonheme iron absorption.  
When we validated our proposed algorithm with complete diet and single meal 
studies data the R2 values were 0.84 and 0.57, respectively. These results suggest that this 
algorithm can be used to predict absorption of nonheme iron for both complete and single 
meal studies. The fact that the algorithm predicted better for the complete diet than for 
the single meal data sets was not surprising since it was developed from complete diet 
datasets. To compare our algorithm with the three most recently developed algorithms (2-
4), we predicted nonheme iron absorption using complete diet data (9, 14-17) and each of 
the different algorithms. These algorithms gave lower R2 values (0.64, 0.69 and 0.72 for 
the Rickard et al. (2), Reddy et al. (4), and the Hallberg and Hulthén (3) algorithms 
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respectively). Further, some of the predicted absorption values arising from the Reddy et 
al. (4) and Hallberg and Hulthén (3) algorithms exceeded 100 % as mentioned above.  
Despite the fact that most of the dietary factors did not contribute significantly in 
explaining variation in absorption, at least based on the data used for this algorithm, we 
included them all in the model to adjust for any difference in their intakes among 
subjects. Our study also shows that between-person differences contribute to the 
variations in iron absorption. In a recent review by Hurrell and Egli (22), it was indicated 
that besides iron status, other host factors such as inflammation and obesity may play a 
significant role, which supports our observation of high between-person variability in 
absorption. Further studies are recommended to probe this area of research.  
One limitation of this algorithm is that all the four data sets used were obtained in 
the United States. However, the diets included wide ranges of intakes with dietary 
modification which makes the algorithm applicable to other countries. In conclusion, we 
have developed a user friendly model for estimating nonheme iron absorption from the 
complete diet. This model can predict nonheme iron absorption with high accuracy and 
will be useful in estimating iron absorption among populations. To estimate nonheme 
iron absorption using our proposed algorithm we recommend the use of mean daily 
intake of nutrients estimated from three or more days’ dietary records, and serum ferritin 
concentration preferably individual subject values. 
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Table 1 Mean daily intakes for dietary factors, serum ferritin concentration and nonheme iron absorption 
by diet type1 
1Values are from four different studies (6-8 and unpublished data) 
2Reported values are median (10th, 90th percentile), n = 53 
3Diet was high in one of four dietary factors (meat, ascorbic acid, calcium or tea) 
4Diet was low in one of four dietary factors (meat, ascorbic acid, calcium or tea) 
5MFP: Meat, fish and poultry 
61 cup (240mL) of black tea= 2 cups of iced tea or 1.5 cups of herbal tea or coffee  
7Reported values are geometric mean [10th, 90th percentile]  
 
 
Table 2 Summary for mixed model for predicting nonheme iron absorption (%).  
Effect Group name/Factor Coefficient SE t-value P-value 
Partial R2 
(%) 
Random 
effects 
IDa (Intercept) - 0.07 - - 
 
Residual - 0.07 - -  
Fixed 
effectsb 
Intercept 6.294 1.04 6.06 <0.0001  
Ferritin, µg/L -0.709 0.10 -6.88 <0.0001 35.30 
Ascorbic acid, mg 0.119 0.07 1.62 0.11 0.79 
MFP, g 0.006 0.02 0.28 0.78 0.03 
Tea, cups -0.055 0.04 -1.28 0.20 0.09 
Phytate, mg -0.247 0.15 -1.70 0.09 0.84 
Calcium, mg -0.137 0.09 -1.49 0.14 0.01 
Nonheme iron, mg -0.083 0.17 -0.50 0.62 0.81 
a Stands for subjects’ ID 
bAll fixed effect variables were log transformed using natural log  
Factor/Nutrient Typical2 High2,3 Low2,4 Total 
Phytate, g 0.61 (0.34, 0.86) 0.53 (0.30, 1.02) 0.61 (0.35, 0.98) 0.57 (0.33, 0.96) 
Nonheme iron, mg 10.3 (6.9, 19.3) 9.9 (6.5, 18.5) 10.7 (6.4, 17.2) 10.3 (6.5, 18.6) 
Calcium, g 0.81 (0.40, 1.23) 0.88 (0.39, 1.40) 0.65 (0.22, 1.26)  0.77 (0.31, 1.35) 
Ascorbic acid, mg 85 (32, 196) 78 (27, 256) 54 (28, 135) 73 (28, 236) 
MFP5, g 94 (39, 228) 108 (43, 242) 82 (0, 162) 91 (11, 215) 
Tea6, cups 0.0 (0.0, 0.6) 0.1 (0.0, 3.0) 0.0 (0.0, 0.7) 0.0 (0.0, 1.1) 
Serum ferritin7, µg/L 41 [17, 86] 41 [17, 86] 41 [17, 86] 41 [17, 86] 
Absorption7, % 4.3 [1.6, 12.4] 5.3 [1.8, 20.5] 5.7 [1.9, 14.5] 5.0 [1.7, 16.9] 
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Figure 1 Diagnostic plots for the complete diet based nonheme iron absorption model. Residual plot of 
standardized residuals vs fitted values (A), and a plot of observed percent absorption in the natural log 
against the fitted values (B).  
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Figure 2 Observed vs. predicted absorption for single meal (A) and complete diet (B) data using the 
complete diet based iron absorption algorithm. When we used our algorithm to predict absorption from 
published data, the R2 values were 0.57 (n=19; P< 0.001) and 0.84 (n=23; P<0.0001) for single meal 
and complete diet data, respectively. For B, data were from five different studies:    (9),     (14),     (15),        
     (16),      (17). The predicted values were estimated using reported mean dietary intakes and serum 
ferritin concentration for different arms of each study. In cases where mean ferritin for the different 
arms were not provided in the study, the overall mean was used for each arm. 
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CHAPTER 4. ESTIMATING IRON BIOAVAILABILITY FROM THE US 
DIET 
A paper to be submitted to the Journal of Nutrition 
Seth M Armah1,2, Alicia Carriquiry3, Manju B Reddy1,4     
Abstract 
Iron bioavailability from the US diet has been estimated to be 18 %. This 
value was derived from a single human absorption study. New data arising from 
recent studies, however, suggest that it may be time to revisit this bioavailability 
estimate. In this study, we estimated iron bioavailability from the US diet using our 
recently reported complete-diet based algorithm. We used dietary intake and 
biomarker information from the National Health and Nutrition Examination Survey 
(NHANES, 2001-2002), MyPyramid Equivalents Database (MPED), and the Food 
and Nutrient Database for Dietary Studies (FNDDS). The survey package in R was 
used for estimating means, percentiles and their confidence intervals taking into 
account the strata, primary sampling units (PSU) and the appropriate survey weight. 
We implemented two different approaches to estimate total absorption. In the first 
approach, we used all survey participants but adjusted the geometric mean of 
nonheme iron absorption to 15 μg/L ferritin to mimic values of individuals with no 
iron stores; in the second approach, absorption was estimated only for non-anemic 
subjects with no iron stores. In both approaches, we considered estimating 
bioavaiability for subjects with no iron store since that is conventionally done to 
estimate the upper ceiling of absorption. A total sample size of 6,631 was used based 
                                                          
1 Department of Food Science and Human Nutrition, Iowa State University. 
2 Primary author and researcher. 
3 Department of Statistics, Iowa State University. Involved in study design and manuscript 
preparation. 
4 Corresponding author. Involved in study design and manuscript preparation. 
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on availability of dietary and iron status biomarker data and C-reactive protein (CRP) 
concentration ≤ 6 mg/L. In the sample, mean ferritin, CRP and haemoglobin 
concentrations were 58.4 µg/L, 1.6 mg/L and 14.3 g/dL respectively. Mean intakes of 
vitamin C, calcium, tea (black tea equivalents), meat fish and poultry (MFP), 
nonheme iron and phytate among sample individuals were 94 mg, 920 mg, 0.3 cups, 
128 g, 14.3 mg and 719 mg respectively. Nonheme iron absorption ranged from 1.9 % 
among men (19-50 years) to 7.3 % among children 3-8 years. The estimated total iron 
absorption was 15.49 % or 15.06 % depending on which approach was used to carry 
out the calculations. This study provides useful data for evaluating the current value 
of iron bioavailability from the US diet. 
Introduction 
Bioavailability has been defined as the fraction of the ingested nutrient that is 
absorbed and subsequently utilized for normal physiological functions (1). Iron 
bioavailability is of interest because poor absorption is considered to be a major 
contributing factor to the prevalence of iron deficiency worldwide. In the developing 
world alone, over 3.5 billion people are either iron deficient or have iron deficiency 
anemia (2). In the United States, the prevalence of iron deficiency was estimated to be 
9 % among non-pregnant women 20-49 years old using the currently popular body 
iron model (3).  When the relatively older ferritin model is used, however, the 
estimated prevalence of iron deficiency jumps to 16 % (3). Total iron absorption from 
the diet can be estimated by combining the fractional absorptions from nonheme and 
heme iron sources. While it is widely accepted that approximately 25 % of heme iron 
is absorbed (4), there is considerable variation in the proportion of nonheme iron that 
is absorbed, because it is influenced markedly by iron status and to some extent by 
dietary factors (5). Thus, estimates of nonheme iron bioavailability have differed 
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greatly in the literature as a result of different combination of personal and dietary 
factors (6-12).  
Hallberg et al. (13) estimated that total iron bioavailability for a typical 
Western-type diet may range from 14 –17 % among subjects who are border-line 
deficient in terms of iron (serum ferritin < 15 µg/L).  In their work, they considered 
bioavailability estimates for Swedish, French and US diets.  The World Health 
Organization (WHO) has proposed a  bioavailability of 15 % for Western-type diets 
that are high in fruit, vegetables, meat and fish,  and of 12 % for a more typical 
Western diet  with less intake of the above mention foods (14). In the US and Canada, 
the U.S. Institute of Medicine (IOM) and Health Canada have established that total 
iron bioavailability is 18 %. This estimate was based on data from a study in which 
absorption was measured among 15 subjects who consumed their typical diet for two 
weeks (15, 16). The current estimate of total absorption is based on nonheme iron 
absorption from the above study corrected to a ferritin concentration of 15 µg/L plus 
heme iron with absorption assumed to be 25 %.   
There are several reasons why it is critical to accurately estimate the iron 
bioavailability in the diet of Americans. First, bioavailability is required for setting the 
Dietary Reference Intakes (DRIs). For example, in setting the current DRIs for iron, 
18 % bioavailability was used  for most age groups, except for pregnant women and 
children under 1 year of age (17). If  iron bioavailability is over-estimated or under-
estimated, then the risk of iron inadequacy at different intake levels would be set to be 
too low or too high, respectively(5). Second, iron bioavailability must be known if we 
wish to estimate the prevalence of inadequate intake of iron in a population (that is, 
the proportion of individuals in a population whose iron intakes do not meet 
requirements). If the bioavailability of iron in the diet is over-estimated, this may 
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result in underestimation of the prevalence of inadequate iron intake and vice versa. 
An estimate of bioavailability is also required to design and implement nutrition 
policies such as food fortification programs.  
Iron bioavailability can be measured using stable or radioactive isotopes of 
iron (8, 18-21). However, these methods are not feasible in population studies because 
they are expensive and cumbersome. Thus, several algorithms have been developed 
for estimating iron bioavailability in the population (22-31) but their limitation is that 
they are based on single meal studies.  As a result, estimates of bioavailability can be 
variable because dietary factors that affect iron absorption (including phytate, vitamin 
C, polyphenols, calcium and animal tissue) may vary across single-meal isotope 
studies and can affect estimation of bioavailability. Hunt (32) argued that this lack of 
repeatability among single-meal models to predict human absorption raises the need 
to develop algorithms that are based on complete-diets (32).  
In this paper, our main objective is to estimate iron absorption from the US 
diet using a complete-diet algorithm that we recently proposed (33). Unlike 
previously published algorithms, this algorithm takes into account iron status in the 
population and was developed using complete diet data.  The National Health and 
Nutrition Examination Survey (NHANES, 2001-2002)(34), My Pyramid Equivalents 
Database (MPED version 1.0) (35), and Food and Nutrient Database for Dietary 
Studies (FNDDS version 1.0) (36) provide nationally representative data with the 
information needed at the individual level to estimate iron absorption from the US 
diet using the algorithm we have proposed. The manuscript is organized as follows: In 
the methods, we describe the sources of data, inclusion criteria, and the procedures for 
the estimation of nutrients and dietary factors intake, especially for phytate and tea 
equivalents which were not reported in the NHANES data. We further explain the 
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calculation of nonheme and total iron absorption. Our estimates of the dietary intakes 
and iron status biomarkers by demography as well as nonheme and total iron 
absorption are presented in the results section. Comparison of our results to existing 
literature and limitations of the study are discussed and a conclusion is offered at the 
end of the discussion section.      
Methods 
Data sources and general procedures. In this analysis we used NHANES data 
(2001/2002), MPED version 1, and FNDDS versions 1.0. These data were used 
because the more recent ones do not have information on iron status biomarkers for 
men. We used day one dietary intakes and serum ferritin values for NHANES 
2001/2002 for estimating absorption. Only those individuals with complete 
information for the variables needed to estimate iron absorption were included in the 
analysis (n=6,631). Pregnant and lactating women as well as individuals with C-
reactive protein (CRP) > 6 mg/L were excluded from the analyses. 
Food and nutrient intakes estimation. We obtained individual-level daily 
nutrient intake of vitamin C, iron and calcium from the NHANES, and estimated 
nonheme iron intake to be 90 % of total iron intake (15). Since NHANES does not 
report phytate intake, we estimated phytate intakes using information about the 
phytate content of phytate-containing foods as reported by the International Zinc 
Nutrition Consultative Group (IZiNCG) (37). The IZiNCG report lists phytate content 
of different foods and food groups. Using these data we estimated the phytate content 
of the various food groups reported in the MPED equivalence data. These values were 
scaled appropriately in order to obtain the phytate content in mg/100 g of each food 
group. We merged the resulting data with the Individual Foods data from NHANES to 
estimate the phytate content of each food consumed by each study participant. The 
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total daily phytate intake was the sum of the phytate amounts contributed by the 
different foods consumed by the individual during the day. 
We estimated polyphenol intake as black tea equivalents (cups) since the 
polyphenol content in foods and beverages is not reported in NHANES. Tea, coffee 
and related beverages reported in the FNDDS were assigned black tea equivalents 
using the following conversion factors:  2 cups (480mL) of iced tea and 1.5 cups 
(360mL) of herbal tea or coffee were coded as 1 cup (240mL) of black tea (38). These 
values were used to estimate the total number of cups consumed by each subject.  
Consumption of meat, fish and poultry (MFP) was estimated using the 
appropriate MPED data which provide daily intake of MFP for each subject in 
MyPyramid equivalents. The MFP equivalents were converted to grams using a 
conversion factor of 28.35g per ounce. 
Nonheme iron absorption was estimated using the following equation (33):  
Ln Absorption (%) = 6.294 - 0.709 ln (SF) + 0.119 ln (C) + 0.006 ln (MFP+0.1) 
- 0.055 ln (T+0.1) - 0.247 ln (P) - 0.137 ln (Ca) - 0.083 ln (NH),                
where SF is Serum ferritin (µg/L), C is vitamin C intake (mg), MFP is meat, fish and 
poultry  consumption (g), T is black tea equivalents (number of cups), P is estimated 
phytate (mg), Ca is calcium (mg) and NH is nonheme iron (mg). 
Nonheme iron absorption was estimated at the individual level and geometric 
means and percentiles were estimated for different groups and subpopulations. 
In estimating total iron absorption for the US population, we used two 
different approaches. In the first approach we adjusted the geometric mean of 
nonheme iron absorption to a serum ferritin concentration of 15 µg/L. In the second 
approach, we estimated iron absorption choosing only the subjects who were iron 
deficient (nonanemic but with ferritin value < 15 µg/L). The procedure for the first 
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approach was as follows: Nonheme iron absorption was adjusted for ferritin (15 µg/L) 
using the following equation which was developed based on the inverse relationship 
of ferritin and nonheme iron absorption (16). 
Log [Adj Abs (%)] = log [Obs Abs (%)] + log [Obs Ferritin (µg/L)]    
 - log [15 (µg/L)] 
 where Adj Abs is adjusted nonheme absorption, Obs Abs is observed nonheme 
absorption (geometric mean), and Obs Ferritin is observed serum ferritin (geometric 
mean). To estimate total absorption, we used the following equation (15): 
Tot Abs (%) = (Adj Nonheme Abs (%)  X  0.9) + (Heme Abs X 0.1),     
where Tot Abs is total absorption, Adj Nonheme Abs is the adjusted nonheme iron 
absorption and Heme Abs is heme iron absorption.  
We used a conservative value of 25 % for heme iron absorption (4), and 
assumed that 90 % of dietary iron in the typical US diet is nonheme with 10 % as 
heme iron (15).  
In the second approach, instead of adjusting the geometric mean of nonheme 
iron absorption to 15 µg/L, we estimated absorption for only a sub-sample of the 
subjects who have no iron stores but are not anemic (13, 15). The presence or absence 
of anemia was established using WHO cut-off values for hemoglobin concentration 
(39). To determine whether an individual had no iron stores, we used the threshold: 
serum ferritin < 15 µg/L. Thus, we excluded anemic individuals as well as individuals 
with ferritin greater than 15 µg/L. 
We used the R software version 12.2.2 for statistical analysis. We estimated 
percentiles, means and confidence intervals using the survey package in R taking into 
account the strata, primary sampling unit (PSU) and appropriate sampling weight. 
Student t-test (2-tailed) was used to compare means of nonheme iron absorption and 
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dietary factor intakes among sub-populations. Statistical significance was set at 
p<0.05. Serum ferritin and nonheme iron absorption were log-transformed using the 
natural log to approximate normality. The transformed values were used for all 
statistical analyses/tests and final estimates were converted into original scale. 
Results 
Summaries by age and gender. In these analyses, mean daily intakes for 
vitamin C, calcium, phytate and MFP for all subjects were 94 mg, 920 mg, 719 mg 
and 128 g respectively (Table 1). Average daily polyphenol beverage intake for all 
subjects (both drinker and non-drinkers) in black tea equivalents, was 0.30 cups. 
Intake of most dietary components were highest among men (19-50 years) except for 
calcium and tea equivalents. Mean nonheme iron intake ranged from 11.8 mg 
(postmenopausal women) to 17.2 mg (men 19-50 years). Geometric mean of 
hemoglobin concentrations ranged from 13.1 g/dL in children 3-8 years to 15.6 g/dL 
in men 19-50 years, while mean CRP was highest among postmenopausal women 
(2.40 mg/L).   The geometric mean of serum ferritin for all subjects was 58.4 µg/L. 
Serum ferritin concentrations were highest among men 19-50 years (132 µg/L), and 
least among 3-8 year old children (25 µg/L). Nonheme iron absorption was lowest 
among men 19-50 years (1.9 %). Various percentiles of the observed distribution of 
the different components and nonheme iron absorption are shown in Table 2.   
Summaries by ethnicity. Further, demographic differences in consumption of 
the dietary components we consider and in ferritin concentrations are shown in Table 
3. Figure 1 compares nonheme iron absorption by ethnicity (A) and gender (B). 
Nonheme iron absorption was significantly lower for non-Hispanic Whites than for 
both non-Hispanic Blacks (P < 0.0001) and Mexican Americans (P < 0.0001). Non-
Hispanic Whites had lower vitamin C and MFP intake and higher ferritin 
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concentration, calcium, phytate and tea intakes than non-Hispanic Blacks (P < 0.05) 
(P-values not shown in the table). Similarly, non-Hispanic Whites had higher ferritin 
concentration and tea intake and lower vitamin C intake than Mexican Americans (P 
< 0.05). These differences may explain the variation in estimated iron absorption. 
When comparing males and females, we found that nonheme iron absorption was 
higher in females (5.55 %) than in males (2.56 %).  This difference in absorption was 
significantly different from zero (P < 0.0001).  Males had higher intake of all dietary 
components associated with iron absorption than females and all the differences were 
statistically significant (P < 0.05) except in the case of intake of black tea equivalents 
(P = 0.45). Females also had a lower serum ferritin concentration than males (35.5 
µg/L and 92.2 µg/L for females and males respectively) (P < 0.0001). 
Total iron bioavailability estimation. After correcting nonheme iron 
absorption to a serum ferritin of 15 µg/L and adding fractional absorption from heme 
iron, the percentage total absorption was 15.49 % (n= 6,631). When we estimated 
absorption using the second approach (only subjects who were nonanemic but lacked 
iron stores, n = 678), the total iron absorption was 15.06 %.  
Discussion 
Despite global efforts to improve iron nutrition in at-risk populations, iron 
deficiency anemia remains a challenge (40). In the US, among most at-risk 
populations, the prevalence of iron deficiency is high even at present (41, 42) even 
though the US diet is high in sources of heme iron and wheat and other grain flour is 
fortified with highly available iron. One possible explanation for this persistent 
deficiency is that the bioavailability of iron in the diet of Americans has been over-
estimated; as a consequence, the prevalence of inadequate intakes may have been 
under-estimated. In this study, we revisit the problem of estimating iron absorption 
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from dietary intake and iron status information.  To do so, we use data from 
participants in NHANES, a nationwide food consumption and health survey.  
 From the survey, we estimated mean daily calcium and vitamin C intakes to be 
920 mg and 94 mg respectively. Moshfegh et al. (43) have reported usual intake levels 
of these nutrients as 892 mg and 91.8 mg both of which are within our estimated 
confidence intervals. While a national estimate of daily phytate intake in the US 
population is scanty, our analysis suggests a mean daily intake of 719 mg is plausible. 
We also estimated mean MFP intake to be 128 g/day which is consistent with the 
amount reported by Daniel et al. (44) based on NHANES 2003-2004 survey data.  
Various studies have estimated iron absorption from the complete diet, 
particularly in the case of nonheme iron absorption. Among four studies that 
estimated nonheme iron absorption from typical US diets, the values ranged from 4.6 
to 7.4 (7, 11, 16, 45). However where meal compositions were varied to increase or 
decrease intake of selected factors, reported nonheme iron absorption include values 
as low as 0.7 % and values higher than 10 % (6, 9, 10, 12). In this study, when 
estimated for different age and gender groups, nonheme iron absorption ranged from 
1.9 % in men (19 to 50 year) to 7.3 % among children (3-8years). It was also clear 
that differences in nonheme absorption among the groups are largely due to 
differences in iron status between survey participants. Generally, groups that had high 
ferritin levels also had low nonheme iron absorption, and vice versa (Table 1).  Our 
study also found that nonheme iron absorption was higher among women (all age 
groups combined) (5.55 %) than among men (2.56 %). This difference may be largely 
due to the lower serum ferritin concentration that was found among women compared 
to men. Women also had lower intakes of inhibitors of iron absorption such as 
calcium, nonheme iron and phytate than males. Tea equivalents intake did not differ 
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significantly by gender and thus may not contribute to the discrepancy in iron 
absorption between the gender groups. With respect to race, iron absorption was 
lower among non-Hispanic Whites than among non-Hispanic Blacks or Mexican 
Americas. We can only explain these differences by disparities in ferritin 
concentrations and in the composition of the diet in the three race-ethnicity groups, 
since the algorithm that we used to estimate iron absorption does not include genetic 
and interpersonal attributes as explanatory variables. We found that non-Hispanic 
Whites had a higher ferritin concentration and tea intake, and a lower vitamin C 
intake than both non-Hispanic Blacks and Mexican Americans (P<0.05). Also, non-
Hispanic Whites had higher intake of calcium and phytate and lower intakes of MFP 
than non-Hispanic Blacks (P < 0.01).   
Using the two different approaches to estimate total iron absorption yielded 
similar values (15.49 % when nonheme absorption was adjusted to 15 µg/L ferritin, 
and 15.06 % when only nonanemic subjects with no iron stores were included). Our 
results therefore suggest that the bioavailabilty of iron in the US diet is 15 % rather 
than 18 % as is currently assumed. To validate our results, we considered data arising 
from three studies in which nonheme iron absorption was measured from the typical 
US diet consumed over a five-day period (7, 11, 45). From these studies we selected 
only those subjects with ferritin concentration of 15 µg/L or less. Total iron 
absorption for these subjects based on measured fractional nonheme iron absorption 
and a conventional heme iron absorption of 25 % was 15.5 % even though the number 
of subjects meeting this criteria was small (n=5).  In their estimation of iron 
bioavailability from Western-type diets, Hallberg and Rossander-Hultén (13) obtained 
a value of 16.6 % for the United States diet. However, this estimate was based only on 
data for women. The researchers suggested that an average value for long term iron 
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bioavailability in western type diets may be approximately 15 % among borderline 
iron deficient subjects, with a likely range of 14-17 %. In a systematic review of iron 
absorption from whole diets, Collings et al. (46) have suggested that even among 
individual with low iron stores, iron bioavailability may be less than 15 % particularly 
if they are consuming a low bioavailability diet. Their model suggests that individuals 
with ferritin concentrations of 12 and 15 µg/L consuming high bioavailability diets 
will absorb 13.9 and 11.8 % of nonheme iron respectively. This translates to 15.0 and 
13.1 % total iron bioavailability respectively assuming that 90 % of the dietary iron is 
nonheme and that 25 % of heme iron is absorbed. 
An important issue that deserves revisiting is the whole idea of estimating 
absorption using information from individuals with no iron stores (Ferritin ≤ 15 µg/L) 
or adjusting absorption to a ferritin level of 15 µg/L. This practice is questionable 
when we consider that the geometric mean of ferritin for the entire US population is 
well above this value. By basing estimation of absorption on individuals with no iron 
stores, we tend to obtain higher estimates for bioavailability than we would when 
considering the entire population.  Further, this approach raises questions about iron 
absorption in individuals with high iron stores (5). On the plus side, the current 
methodology results in an upper bound of iron absorption (or maximum absorption)  
from the US diet, and thus is useful in setting lowest ceilings for the different DRIs 
for iron (13). When we estimated total iron absorption for all subjects without 
adjusting for serum ferritin by any of the two different approaches described earlier, 
the estimated mean absorption for the entire population was 5.8 %. This value is less 
useful, however because it hugely under-estimates iron absorption for individuals 
with low iron stores and at the same time overestimates absorption for individuals 
with very high iron stores.  From a public health point of view, using the maximum 
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absorption value as the national estimate is the lesser of two evils in that it leads to 
over-estimation of absorption, but only in individuals with adequate iron stores.  For 
example if we estimate the prevalence of inadequate iron intake among men using the 
maximum iron absorption threshold, we are likely to under-estimate prevalence of 
inadequacy. However, it is also the case that we rarely find iron deficiencies among 
men.  
Some limitations of this study are discussed below. First, since phytate intake 
was not part of the NHANES survey variables, we estimated it using the method 
described earlier. To minimize errors, we used phytate content values from a reliable 
source (37).  Secondly, because it is not feasible from a practical point of view to 
measure iron absorption in a nationally representative sample of individuals, we 
estimated absorption using an algorithm proposed by Armah et al. (33). The algorithm 
we implemented is based on a complete diet and includes iron status as part of the 
model. As discussed in (33), the prediction model for iron absorption has been 
validated using published data with reliable predictive power. The algorithm, however 
does not capture the effect of genetic and interpersonal variability in iron absorption. 
Therefore, we predict mean iron absorption for all individuals with the same values of 
iron status and of the dietary factors included as explanatory variables in the model.   
Also, the algorithm was developed with data for adults 19 to 38 years old, and thus 
absorption prediction with this model may be most appropriate for this group. 
Polyphenols constitute one the main inhibitors of iron absorption yet consumption of 
polyphenols is not included in NHANES.  To overcome this problem, we used tea, 
coffee and other polyphenol containing beverages intake expressed in black tea 
equivalents to approximate intake of polyphenols at the individual level.  In 
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conclusion, the results of this study suggest that the bioavailability of iron in the US 
diet is about 15 %, lower than 18 % assumed at present.  
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Table 1 Summary of nutrients intake, nonheme iron absorption and serum ferritin concentration for subjects in NHANES 2001/20021,2   
 
3-8 y 
(n= 836) 
9-18y 
Boys 
(n=1107) 
9-18y 
Girls 
(n=1113) 
19 – 50y 
Men 
(n=1,127) 
>50 
Men 
(n=811) 
19-50y 
Women 
(n=936) 
>50y 
Women 
(n=701) 
Total3 
(n= 6,631) 
Vitamin C, mg 
82 
(74-90) 
94 
(86-103) 
82 
(72-92) 
103 
(95-111) 
100 
(91-108) 
83 
(76-90) 
94 
(87-101) 
94 
(89-99) 
Calcium, mg 
941 
(897-984) 
1177 
(1084-1271) 
868 
(819-918) 
1070 
(1018-1123) 
878 
(827-929) 
783 
(728-837) 
720 
(687-754) 
920 
(890-950) 
Tea4, cups 
0.10 
(0.06-0.14) 
0.12 
(0.09-0.15) 
0.14 
(0.10-0.18) 
0.35 
(0.31-0.39) 
0.43 
(0.37-0.48) 
0.30 
(0.27-0.34) 
0.45 
(0.40-0.50) 
0.30 
(0.28-0.33) 
MFP5, g 
77 
(71-83) 
127 
(119-136) 
88 
(81-95) 
182 
(176-188) 
141 
(131-152) 
113 
(106-120) 
88 
(82-95) 
128±2 
(125-132) 
Nonheme iron, 
mg 
12.0 
(11.3-12.7) 
16.7 
(15.9-17.5) 
12.4 
(11.8-12.9) 
17.2 
(16.3-18.0) 
15.2 
(14.2-16.3) 
12.3 
(11.8-12.8) 
11.8 
(11.2-12.3) 
14.3 
(13.8-14.7) 
Phytate, mg 
551 
(516-585) 
734 
(696-773) 
604 
(571-637) 
855 
(809-900) 
794 
(717-872) 
644 
(584-704) 
662 
(585-738) 
719 
(684-753) 
Absorption of 
nonheme iron6, 
% 
7.32 
(6.85-7.83) 
5.02 
(4.82-5.23) 
7.25 
(6.92-7.60) 
1.93 
(1.84-2.02) 
2.03 
(1.89-2.18) 
6.21 
(5.96-6.46) 
3.48 
(3.26-3.72) 
3.70 
(3.61-3.80) 
Serum ferritin6, 
µg/L 
24.9 
(22.5-27.6) 
36.4 
(34.4-38.5) 
24.7 
(23.3-26.1) 
131.7 
(123.7-140.2) 
131.0 
(117.9-145.5) 
29.5 
(27.5-31.8) 
69.7 
(63.5-76.6) 
58.4 
(56.8-60.1) 
HB6, g/dL 
13.1 
(12.9-13.2) 
14.6 
(14.4-14.8) 
13.6 
(13.4-13.8) 
15.6 
(15.4-15.8) 
15.0 
(14.8-15.2) 
13.5 
(13.3-13.6) 
13.8 
(13.6-14.0) 
14.3 
(14.1-14.5) 
CRP, mg/L 
0.76  
(0.65-0.87 
0.77 
(0.69-0.86) 
0.87 
(0.77-0.97) 
1.60 
(1.50-1.71) 
1.98 
(1.85-2.11) 
1.90 
(1.79-2.02) 
2.40 
(2.26-2.55) 
1.61 
(1.57-1.65) 
1Estimates are for only subjects with complete data for estimating nonheme iron absorption 
2Values are mean (95 % confidence interval) 
3Excludes pregnant and lactating women 
41 cup (240mL) of black tea= 2 cups of iced tea or 1.5 cups of herbal tea or coffee  
5MFP: Meat, fish and poultry 
6Geometric mean 
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Table 2 Percentiles of nutrients intake, nonheme iron absorption and serum ferritin concentration among subjects in NHANES 2001/20021 
Nutrient/Factor 10th 25th 50th 75th 90th Mean 
Vitamin C, mg 
12 
(11-13) 
26 
(24-28) 
59 
(55-64) 
127 
(120-133) 
216 
(207-227) 
94 
(89-99) 
Calcium, mg 
311 
(294-324) 
496 
(465-522) 
786 
(759-812) 
1180 
(1149-1212) 
1670 
(1609-1719) 
920 
(890-950) 
Tea2, cups 
0.00 
(0.00-0.00) 
0.00 
(0.00-0.00) 
0.00 
(0.00-0.07) 
0.33 
(0.28-0.42) 
1.00 
(1.00-1.00) 
0.30 
(0.28-0.33) 
MFP3, g 
11 
(5-17) 
51 
(46-56) 
102 
(99-106) 
176 
(170-182) 
268 
(259-278) 
128 
(125-132) 
Nonheme iron, mg 
6.1 
(5.9-6.3) 
8.7 
(8.5-8.9) 
12.3 
(12.0-12.6) 
17.5 
(16.8-18.2) 
24.6 
(23.3-25.9) 
14.3 
(13.8-14.7) 
Phytate, mg 
240 
(226-253) 
365 
(349-382) 
567 
(543-595) 
881 
(836-926) 
1323 
(1262-1415) 
719 
(684-753) 
Absorption of nonheme iron4, % 
1.24 
(1.18-1.29) 
1.95 
(1.87-2.01) 
3.73 
(3.59-3.85) 
6.65 
(6.43-6.86) 
10.73 
(10.33-11.06) 
3.70 
(3.61-3.80) 
Serum ferritin4, µg/L 
15.0 
(14.0-16.0) 
27.0 
(26.0-28.0) 
58.0 
(56.0-61.0) 
135.0 
(129.0-141.0) 
241.0 
(230.0-253.0) 
58.4 
(56.8-60.1) 
1Estimates are for only subjects with complete data for estimating nonheme iron absorption (n=6,631); Values are percentile (95 % confidence interval) 
21 cup (240mL) of black tea= 2 cups of iced tea or 1.5 cups of herbal tea or coffee  
3MFP: Meat, fish and poultry  
4Values are geometric mean (95% confidence interval) 
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Table 3 Dietary intakes and iron status by gender and ethnicity1,2 
 Phytate, 
mg 
MFP, 
 G 
Tea,  
Cups 
Calcium,  
mg 
Vitamin C, mg Nonheme 
iron3, mg 
Ferritin4, 
µg/L 
Nonheme iron 
absorption4, % 
All (n=6631) 719 
(684-753) 
128 
(125-132) 
0.30 
(0.28-0.33) 
920 
(890-950) 
94 
(89-99) 
14.3 
(13.8-14.7) 
58.4 
(56.8-60.1) 
3.70 
(3.61-3.80) 
Gender         
Males 
(n=3456) 
797 
(756-838) 
156 
(151-160) 
0.31 
(0.27-0.35) 
1041 
(1001-1080) 
102 
(95-109) 
16.3 
(15.6-17.0) 
92.2 
(88.6-96.0) 
2.56 
(2.47-2.65) 
Females  
(n= 3175) 
633 
(595-670) 
98 
(93-104) 
0.29 
(0.26-0.32) 
788 
(758-815) 
85 
(81-89) 
12.1 
(11.7-12.4) 
35.5 
(33.9-37.2) 
5.55 
(5.39-5.72) 
Ethnicity         
Non-Hispanic 
White  
(n= 2870) 
737 
(691-784) 
126 
(122-131) 
0.32 
(0.29-0.36) 
970 
(929-1010) 
89 
(84-94) 
14.5 
(13.9-15.1) 
61.0 
(58.2-63.9) 
3.50 
(337-3.64) 
Non-Hispanic 
Black  
(n= 1601) 
617 
(580-654) 
150 
(141-160) 
0.21 
(0.17-0.25) 
723 
(694-753) 
106 
(94-117) 
13.7 
(13.1-14.3) 
53.8 
(49.0-59.1) 
4.39 
(4.10-4.70) 
Mexican 
American 
(n=1676 ) 
693 
(656-730) 
131 
(121-142) 
0.19 
(0.16-0.22) 
910 
(866-954) 
108 
(102-113) 
14.2 
(13.4-15.0) 
46.8 
(43.1-50.7) 
4.49 
(4.20-4.79) 
Other Race - 
Including 
Multi-Racial 
(n= 193 ) 
719 
(604-834) 
127 
(108-145) 
0.37 
(0.26-0.48) 
680 
(602-757) 
111 
(93-128) 
13.0 
(12.2-13.9) 
62.6 
(51.7-75.8) 
3.74 
(3.23-4.33) 
Other Hispanic 
(n=291) 
708 
(602-816) 
109 
(89-129) 
0.31 
(0.20-0.41) 
853 
(778-929) 
102 
(88-116) 
13.7 
(13.1-14.3) 
52.9 
(43.6-64.0) 
4.07 
(3.54-4.68) 
1Estimates are for only subjects with complete data for estimating nonheme iron absorption (n=6,631); Values are percentile (95 % confidence interval) 
21 cup (240mL) of black tea= 2 cups of iced tea or 1.5 cups of herbal tea or coffee  
3MFP: Meat, fish and poultry  
4Values are geometric mean (95% confidence interval) 
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Figure 1A Nonheme iron absorption among different ethnic groups. Absorption values for bars with            
different alphabets are significantly different (P < 0.005). 
 
 
Figure 1B  Nonheme iron absorption by gender. Different alphabets on bars indicate significant difference in 
absorption (P < 0.0001). 
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CHAPTER 5. ADAPTATION OF IRON ABSORPTION IN HUMANS WITH 
HIGH PHYTATE DIET CONSUMPTION 
A paper submitted to the Journal of Nutrition 
Seth M Armah12, Erick Boy3, Dan Chen1,4, Priscila Candal1,4 and Manju B 
Reddy1,5
Abstract 
Background: Phytate is one of the main inhibitors of nonheme iron absorption. 
High phytate consumption is of concern in developing countries because of the high 
prevalence of iron and zinc deficiency in these countries. Objective: In this study, we 
investigated whether individuals adapt to the inhibitory effect of phytate on iron 
bioavailability. Design: Female subjects with ferritin < 30 µg/L (n=28) were randomized 
into two groups of 14, after matching for ferritin. Each group consumed either high or 
low phytate foods that were provided for 8 weeks. Iron bioavailability from a high 
phytate test meal was measured using area under the curve (AUC) for serum iron at 
baseline and after the intervention. Results: Due to the dietary modification, phytate 
intake changed significantly (P <0.01) in both groups. No significant changes were 
observed in ferritin, transferrin receptor, hepcidin, and C-reactive protein concentrations 
in both groups. AUC increased significantly (P < 0.05) in the high phytate group (640 to 
905 µmol/L) but the decrease (337 to 267 µmol/L) in the low phytate group was not 
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significant. We found a strong positive correlation between mean phytate intake and 
AUC (r = 0.70, P <0.0001) at post-intervention but not at baseline, and a negative 
correlation between hepcidin and AUC at both baseline (r = -0.43; P = 0.01) and post 
intervention (r = -0.41; P = 0.02). Phytate intake was also negatively correlated with 
hepcidin concentration at post-intervention (r = 0.40; P = 0.02). Conclusion: Our data 
suggests that individuals who consume a habitual high phytate diet may adapt to the 
inhibitory effect of phytate on iron absorption. Further studies are needed to explore the 
possible mechanism by which the adaptation occurs. 
Introduction 
Numerous studies have been conducted to investigate the effect of dietary factors 
on iron absorption (1-7). These dietary factors include meat, calcium, ascorbic acid, 
tea/polyphenols, phytic acid and nonheme iron. These, along with iron status of the 
individual, are well recognized determinants of iron absorption based on single meal 
absorption studies (8, 9). Studies have however suggested that the effect of dietary factors 
may be dampened in the usual/complete diet. In one study Cook et al. (10), demonstrated 
that the effect of these dietary factors on iron absorption is exaggerated in single meal 
studies. They reported that modifying the diet to contain high levels of meat and other 
enhancers resulted in only a small increase in absorption from the complete meal, while 
an exaggerated increase was observed in the single meals. Similarly an inhibitory diet, 
limited in meat and ascorbic acid and generous in phytic acid, calcium and polyphenols, 
consumed over two weeks showed a relatively lower reduction in iron absorption 
compared to what was observed in single meal. In other studies the effect of meat and 
ascorbic acid on nonheme iron absorption from a complete diet was shown to be 
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marginal, compared to the reported enhanced effect (1, 4). In yet another study, no effect 
of 2 g ascorbic acid supplementation for 16 weeks or even 24 months on iron status was 
reported despite an increase in absorption from a single meal (11). Similarly, in a study 
designed to investigate the long-term impact of increasing ascorbic acid containing lime 
juice intake on iron status among Mexican women who were iron deficient, no 
improvement in iron status was found in the experimental group compared to the control 
group and both groups remained iron deficient at the end of the eight month intervention 
(12). Our recent study also showed no significant effect on iron status in premenopausal 
women who consumed soybean diet for 10 weeks (13).  
The dampened effect of dietary factors may be due to the interaction of other meal 
components.  Another possible explanation for the diminished or lack of effect of dietary 
factors in long term studies is that individuals may adapt to the effect of these factors.  
Various studies, including both human and animal research, have investigated this 
hypothesis (14-16). In a study with male subjects after matching for ferritin, nonheme 
iron absorption decreased among subjects consuming high bioavailability diets, and 
increased among those consuming low bioavailability diets (15). The high bioavailability 
diets included close to 400 g/day of meat or poultry, high vitamin C, and no coffee or tea. 
The low bioavailability diet included tea and plenty of whole grain cereals and legumes, 
limited amounts of poultry and fish, with no meat. On the contrary, Brune et al. (14) have 
reported  that no intestinal adaptation to a high phytate diet occurs based on a study in 
which iron absorption was measured from wheat and bran rolls among vegetarians and 
non-vegetarians. In this study, we investigated whether individuals adapt to the inhibitory 
effect of phytate on iron absorption after an eight week modification in phytate intake 
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using the area under the curve (AUC) for serum iron method. The AUC method was 
validated by Conway et al. (17) by showing a strong positive correlation with erythrocyte 
incorporation of isotopic iron.  We hypothesize that  fractional nonheme iron absorption 
from a high phytate test meal will increase in subjects consuming a high phytate diet and 
decrease or not change among those consuming a low phytate diet for eight weeks.  
Methods 
Subjects. Female subject were recruited for this study by sending mass e-mail to 
all female students in Iowa State University in the Spring of 2013. A total of 113 students 
responded, however only 97 participated for initial screening (Figure 1). Prior to 
screening, they were required to read and sign an informed consent document, and all 
procedures, potential risks and benefits were explained to them. The study protocol was 
approved by the Institutional Review Board at Iowa State University (IRB# 12-470). 
Potential subjects were required to go through three different stages of screening. At first 
screening they completed health and medical history questionnaire and their height and 
weight were measured for BMI assessment. Subjects who were eligible came back for 
ferritin eligibility (<30 ug/L) and then for pregnancy test. We determined that 14 subjects 
were needed in each group to determine a change in AUC by one-third (33 %) as 
significant with 80 % power and at an alpha level of 0.05 (15, 17). A total of 32 subjects 
were recruited for the study based on ferritin (<30 ug/L) and BMI within the normal 
range (18.5-24.9 kg/m2). Participation criteria included non-smoking, non-lactating, non-
pregnant, not taking any drug that interferes with iron absorption, and should not have 
any gastro-intestinal disease/condition that can affect absorption. The 32 recruited 
subjects were first matched for ferritin and then randomized, into either high or low 
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phytate diet group (n=16 per group). The randomization and allocation of subjects was 
done by a person who was not involved in the study using computer based 
randomization. 
 Study protocol. After recruitment, subjects were asked to keep a three day dietary 
record (two weekdays and a weekend) prior to reporting to the Nutrition and Wellness 
Research Center (NWRC) at Iowa State University for baseline absorption measurement. 
Iron absorption from a high phytate test meal to which 10 mg iron as FeSO4 has been 
added was measured using the AUC for serum iron (17). The test meal was composed of 
a small corn tortilla (27.2g), 100g black beans (drained from can), 50g cooked white rice, 
30g salsa and 120g orange juice.  Subjects were asked to fast overnight before coming to 
the NWRC for the first absorption measurement. A baseline blood sample was collected 
after which test meal was administered. After consuming the test meal, blood samples 
were collected every 30 minutes for 4 hours. After the first absorption measurement, 
subjects participated in an eight week dietary intervention in which each subject 
consumed either high or low phytate diets. All food needed for the dietary modification 
was supplied to subjects. Their first two-week food supply was given on the day they 
came for the baseline multiple blood draw. Subjects reported to the NWRC every two 
weeks to pick up food. The high phytate group received whole grain ready-to-eat cereals, 
whole wheat pasta/spaghetti, tortillas, bagels, bread and dinner rolls, corn tortillas, brown 
rice, canned black beans, edamame and tofu, and were encouraged to consume generous 
amounts of nuts and other legume products high in phytate. The low phytate group 
received similar foods made from refined wheat and white rice, eggs and cheese, and 
were instructed to avoid high phytate foods.  At weeks 4 (data not shown) and 7, the 
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subjects were asked again to keep three day dietary records. Post intervention absorption 
measurement with the same meal that was given at baseline was done after the eight 
week dietary intervention. Four subjects dropped out during the study (One got an 
internship and could not continue with the study, one got sick but not related to the 
treatment, one subject did not want to follow the dietary modification and opted to quit, 
and the last one had difficulty with the multiple blood draws and decided to quit.), 
leaving 28 who completed the study (14 in each group). To assess compliance, subjects 
were required to write down daily all the foods they consumed from what they were 
provided. They were required to incorporate the foods they had been provided in at least 
two of their daily meals. Also at the end of the study, they were asked to provide 
information on how frequently they consumed specified high phytate foods listed in a 
food frequency questionnaire. Compliance was estimated as the percentage of days in 
which they included the foods they were provided in at least two of their daily meals. 
Also from the food frequency questionnaire, the total number of times they have 
consumed high phytate foods over the eight week intervention period was estimated as a 
measure of compliance.  
Blood sample analysis.  Before administering the test meal, two separate fasting 
blood samples were collected, one for measurement of hepcidin, and the other for 
measurement of initial (T0) serum iron, C-reactive protein (CRP), transferrin receptor and 
serum ferritin. Multiple blood samples collected after the test meal was consumed were 
analysed for serum iron by the certified lab (Quest Diagostics, Inc), and results were used 
to construct serum iron curve for each subject during a four hour period. Blood samples 
collected were centrifuged and serum was aliquoted into microcentrifuge tubes and 
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frozen until they were analysed. Aprotinin (Fisher Scientific, Pittsburgh, PA) was added 
to the hepcidin sample and it was frozen at -80oC. Samples for measurement of CRP, 
transferrin receptor and ferritin were stored at -20oC until the end of the study when all 
samples were analysed.  CRP, Hepcidin (Hepcidin-25), ferritin and transferrin receptor 
were measured using Enzyme Linked Immunosorbent Assay (ELISA). Kits for the 
measurements were obtained from American Laboratory Products Company (ALPCO 
Diagnostics, Salem, NH) for CRP, Penninsula Laboratories (San Carlos, CA) for 
hepcidin-25, and Ramco Laboratories Inc. (Stafford, TX) for ferritin and transferrin 
receptor.  Dietary data were analysed using the Nutrition Data System for Research 
(NDSR, University of Minnesota, MN). 
Statistical analysis. Data were analysed using the Graphpad Prism 6 (GraphPad 
Software, Inc. La Jolla, CA). For all variables, analyses were done for all 28 subjects who 
completed the study (14 per group). AUC for serum iron as a primary outcome was 
estimated for each subject and the geometric mean was reported for each group. We also 
estimated percentage iron recovery at baseline using the method described by Conway et 
al. (17) to correlate with AUC. We estimated total body iron using the equation by Cook 
et al. (18). For iron status indices and AUC, the data were log transformed for statistical 
analysis and the original values were recovered by back-transforming. Geometric means 
were reported for the iron status biomarkers except for body iron where median was 
reported because some of the values were negative. Median, 10th and 90th percentiles 
were reported for the dietary variables. Paired t-test was used to compare baseline and 
post values of biomarkers of iron status, dietary intakes and AUC within each group. 
Comparisons between groups of baseline or post measurements were done using 
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independent t-test. Differences were considered statistically significant at P ≤ 0.05. 
Pearson correlation was used to assess relationships among AUC, phytate intake and 
hepcidin concentration. For correlation analyses data for all 28 subjects were combined 
instead of analysing by groups. 
Results 
Of the 28 subjects who completed the study, there were 22 Whites, 3 Asians, 2 
Blacks and 1 Latino. The mean (range) height, weight, and BMI of all 28 subjects at 
baseline were 167 cm (156-180 cm), 62.1 kg (49.0-75.5 kg), and 22.3 kg/m2 (18.5-24.6 
kg/m2). Geometric means for   serum ferritin, transferrin receptor, CRP and hepcidin 
concentrations were 19.0 µg/L, 5.2 µg/mL, 0.77 mg/L and 2.3 ng/mL. None of the above 
mentioned measurements differed significantly between the high and low phytate groups 
at baseline, with the exception of hepcidin concentration which was higher in the low 
phytate group than the high phytate group (P = 0.019). Table 1 compares the baseline 
and post-intervention dietary intakes of subjects by groups. There were no significant 
changes in nutrients intake in both groups apart from phytate. Compliance as estimated 
by the percentage of days in which subjects incorporated provided foods in their daily 
meals was 87 % in the low phytate group and 96 % in the high phytate group. Over the 8 
week intervention period, the high phytate group incorporated high phytate foods 271 
times on average compared to 27 in the low phytate group. Based on the changes in 
dietary pattern, phytate intake increased significantly (P <0.01) among the high phytate 
group and decreased significantly (P <0.001) among the low phytate group. 
Changes in biomarkers of iron status and measures of iron absorption are shown 
in Table 2. Ferritin, transferrin receptor, body iron, hepcidin, and CRP did not change 
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significantly within groups. Figure 2, shows the serum iron curves for the high and low 
phytate groups at baseline and post intervention. The curves shown are based on average 
values for each group. For each individual, the curve was obtained by calculating the 
change in serum iron from baseline at 30 minutes intervals for 4 hours after consuming a 
high phytate test meal. AUC increased significantly (P<0.05) by 48 % in the high phytate 
group from 640 to 905 µmol/L, whereas the 21 % decrease in the low phytate group (337 
to 267 µmol/L) was not statistically significant (Table 2). When we estimated percentage 
iron recovery (at maximum) as an estimate of absorption based on the calculation by 
Conway et al. (17), the correlation with AUC was 0.86 (P <0.0001) at baseline. We did 
not include an estimate at post intervention because we did not have all the measurements 
needed for the calculation. In the low phytate group, the geometric mean (range) of 
absorption estimated using this method was 3.1 % (0.4-7.2 %), while it was 5.5 % (1.0-
9.3 %) in the high phytate group.  
The correlations among phytate intake, AUC and hepcidin (for all subjects, n=28) 
are shown in Figure 3. At baseline, no significant correlation was observed between 
phytate intake and AUC (Figure 3 A). However after the intervention (Figure 3B), AUC 
was significantly correlated with phytate intake (r = 0.70; P < 0.0001). Hepcidin 
concentration was inversely correlated with AUC both at baseline (r = -0.43; P = 0.01) 
and at the post-intervention (r = -0.41; P = 0.02) (Figure 3 C and D, respectively). There 
was no significant correlation between hepcidin and phyate intake at baseline (Figure 
3E). However, at post-intervention, as phyate intake increased hepcidin concentration 
decreased (r = -0.40, P = 0.02) (Figure 3F). 
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Discussion 
Phytate is known as one of the major inhibitors of iron absorption (19). Higher 
inositol phosphates like inositol hexaphosphate (IP6) and inositol pentaphosphate (IP5) in 
particular are known to bind to iron and make it unavailable for absorption (20). Hallberg 
et al. (21) have reported a dose dependent inhibition of sodium phytate on iron absorption 
from meals consumed together with radiolabeled wheat rolls. A key reason for the 
concerns about phytate is that it is a major component of the staples in many developing 
countries where iron deficiency prevalence is high (22). Interestingly, studies that have 
investigated the effect of dietary factors on iron absorption in complete diets have 
suggested that their effect may be dampened when the whole diet is considered (10). 
Particularly for phytate, no study has investigated its effect on iron absorption from the 
whole diet assessed over a short or long term to the best of our knowledge. In order to 
determine whether individuals adapt to the effect of phytic acid on iron absorption, Brune 
et al. (14) compared the effect of bran on iron absorption between a vegetarian group and 
a nonvegetarian control group, and found no significant difference, suggesting no 
adaptation. However the average daily phytate intake among the vegetarian group was 
323 mg/day, which is well below what has been reported for many countries. For 
example, median phytate intake in the United Kingdom was estimated to be 809 mg/day 
(23). In most developing countries, daily phytate intake values are even higher (24). In 
this study we investigated whether individuals adapt to the inhibitory effects of phytate 
on iron absorption after long-term phytate consumption. Baseline phytate intakes were 
715 and 793 mg/day for low and high phytate groups respectively which are comparable 
with reported average intake of 750 mg/day for US adults (25).  
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The results of this study also indicate no effect of the intervention on the 
biomarkers of iron status. In the high phytate group there was an increase in serum 
ferritin and body iron and a decrease in transferrin receptor while the low phytate group 
showed a decrease in ferritin concentration. However, none of these changes were 
significant which was expected considering short duration of dietary modification in our 
study. These results are similar to the observation by Hunt and Roughead (15), who 
found that a ten week dietary intervention with a high or low bioavailability diet did not 
affect blood indices of iron status. Since hepcidin concentration was higher in the low 
phytate group than the high phytate group and based on its inverse relationship with iron 
absorption, it was not surprising see to see that baseline absorption and AUC was lower 
in the low phytate group compared to high phytate group. Baseline AUC among the high 
phytate group was about twice that among the low phytate group (640 vs 337 µmol/L). 
Even when we estimated absorption at baseline using the maximum iron recovery 
method, the difference was similar (5.5 % vs 3.1 %).  
Hepcidin is known as a key regulator of iron absorption. It regulates iron 
absorption through ferroportin, the main iron exporter from intestinal cells and 
macrophages. Hepcidin binds to ferroportin and prevents the export of iron, resulting in 
the internalization of the ferroportin and subsequent reduction in iron absorption. Thus 
higher hepcidin concentration leads to lower iron absorption and vice versa (26-29). Our 
results of hepcidin showing negative correlation with AUC at both baseline and post-
intervention support the above relationship. This strong correlation also suggests that the 
AUC for serum iron is a good measure of iron absorption despite the fact that it may not 
be as sensitive as isotopic methods. The AUC method was validated by Conway et al. 
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(17) by showing a strong positive correlation with erythrocyte incorporation of isotopic 
iron. 
There was a strong positive correlation between phytate intake and absorption at 
post intervention (r = 0.70; P < 0.0001), supporting the assertion that long-term phytate 
intake may dampen the inhibitory effect of phytate on iron absorption. In a similar study 
by Hunt and Roughead (15) nonheme iron absorption increased among subjects 
consuming a low bioavailability diet and decreased among those consuming a higher 
bioavailability diet, implying that people adapt to the effect of dietary factors that affect 
iron absorption. At baseline, phytate intake did not show any correlation with absorption. 
This was probably because of the distribution of phytate intake. At baseline, the 10th and 
90th percentiles for phytate intake were 368 mg and 1067 mg respectively, which is a 
smaller range compared to post intervention, when the 10th and 90th percentiles were 318 
and 1521 mg respectively. For the same reason, there was no significant correlation 
between baseline phytate intake and hepcidin concentration, even though a significant 
negative correlation was found between the two variables after the dietary modification. 
While the results of our study suggest that individuals may adapt to the inhibitory effect 
of phytate on iron absorption, this observation was not explained by any of the measured 
biomarkers of iron status since none of them changed significantly after the eight week 
dietary modification. However, based on the correlations found among hepcidin, AUC 
and phytate, we cannot rule out a role of hepcidin in the adaptation in iron absorption.  
Future studies are needed to further investigate the mechanism. The authors would like to 
acknowledge the following limitations of this study. First, compliance of the dietary 
intervention was based solely on records kept by subject since it was not control feeding 
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study. Secondly, subjects in both groups were not required to consume specific amounts 
of the high or low phytate foods they were provided. This was in part to create a 
condition similar to real life scenario and to accommodate individual differences in food 
consumption.  
In conclusion, the results of this study suggest that among individuals with 
habitual high phytate diet consumption, the inhibitory effect of phytate on iron absorption 
may be dampened implying an adaptation to the inhibitory effect of phytate. The findings 
of this study also imply that dietary staples in developing countries can be biofortified 
with iron to reduce iron deficiency despite their high phytate contents since habitual 
consumption of these foods may result in adaptation to the inhibitory effect of phytate.  
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  Table 1 Nutrients intake1 at baseline and post intervention among high and low phytate groups 
 High Phytate (n=14) Low phytate (n=14) 
 Baseline Final Baseline Final 
Fat, g/1000kcals 37 (30, 40) 37(30, 43) 38 (27, 44) 33 (23, 41) 
Protein, 
g/1000kcals 36 (26, 48) 36 (29,50) 38 (31, 53) 38 (33, 46) 
Vitamin C, mg 91 (41, 207) 85 (28, 192) 74 (20, 168) 64 (30, 117) 
Calcium, mg 765 (540, 1278) 805 (571, 1152) 709 (386, 1294) 818 (583, 1362) 
Iron, mg 13.4 (8.1, 20.8) 13.7 (9.7, 21.0) 12.9 (9.7, 19.4) 14.4 (11.2, 16.9) 
Phytate, mg 793 (396, 1094)a 1122 (916, 1602)b 715(362, 949)c 357(300, 487)d 
1Values are median (10th, 90th percentiles). Values with different superscripts are significantly different (P 
<0.05) within the same group based on paired t-test. 
 
Table 2 Iron status biomarkers and serum iron1 at baseline and post intervention 
 High Phytate (n=14) Low Phytate (n=14) 
Baseline Final Baseline Final 
Serum ferritin, µg/L 17.4  
(15.9, 19.1) 
18.7  
(17.0, 20.6) 
20.7  
(17.3, 24.8) 
18.6  
(16.1, 21.5) 
Transferrin receptor, µg/mL 5.0  
(4.5, 5.6) 
4.7  
(4.2, 5.3) 
5.5 
 (4.6, 6.5) 
5.5  
(5.1, 5.9) 
Body iron, mg/kg body weight 2.8  
(0.6, 5.7) 
3.4 
(0.6, 6.1) 
3.3 
 (-1.5, 7.9) 
3.2  
(-0.4, 5.9)  
Hepcidin, ng/mL 1.5  
(1.1, 2.0) 
1.6  
(1.2, 2.2) 
3.6 
 (2.8, 4.7) 
3.8 
 (3.2, 4.5) 
C-reactive protein, mg/L 0.53  
(0.40, 0.69) 
0.67  
(0.50, 0.90) 
1.13 
 (0.70, 1.60) 
1.46 
 (1.09, 1.96) 
AUC for serum iron, µmol/L 640  
(537, 764)a 
905 
 (765, 1070)b 
337  
(269, 421) 
267 
 (213, 334) 
Maximum iron recovery, %2 5.5  
(4.9-6.1) 
NA 3.1  
(2.4-3.9) 
NA 
1 Values are geometric mean (± SE), except for body iron where median (10th, 90th) were reported because 
there were negative values and geometric mean could not be computed. Within the same group, values with 
different superscript are significantly different (P <0.05) based on paired t-test. 
2 Not available at post intervention because hemoglobin concentration that was needed for  calculations 
(17) was not measured. 
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Figure 1 Subject selection 
 
 
 
Assessed for eligibility 
(n=97)  
Did not meet inclusion 
criteria (n=65) 
 
Completed study (n= 14) 
 
Discontinued intervention (n= 2)  
 Got sick (unrelated to treatment) 
(n=1)  
 Time conflict (n=1) 
 
Assigned to low phytate group 
(n=16) 
 
Discontinued intervention (n= 2) 
 Did not want to follow to 
dietary modification (n=1)  
 Difficulty with blood draw 
(n=1) 
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Figure 2 Serum iron curve at baseline (o) and post intervention ( ) for low (n=14) and high (n=14) phytate 
groups. Values are mean + SE. Panel A and B represent serum iron curves for low phytate and high phytate 
groups. The AUC for serum iron curves with different superscripts were significantly different (P <0.05) 
based on paired t-test. 
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Figure 3 Correlations between phytate intake and AUC at baseline (A) and post intervention (B); between 
hepcidin concentration and AUC at baseline (C) and post intervention (D); between phytate intake and 
hepcidin concentration at baseline (E) and post intervention (F). Values are based on Pearson correlation 
test (n=28).  
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CHAPTER 6. GENERAL CONCLUSIONS 
In this study, we have investigated iron bioavailability using statistical and human 
models. We have developed a new algorithm that can be used to reliably estimate 
nonheme iron absorption from complete diets. The findings of this study affirm the fact 
that iron status is a more prominent predictor of nonheme iron absorption than dietary 
factors. Among the dietary factors, only phytic acid was marginally significant in 
explaining variability in nonheme iron absorption. Interperson variability also contributed 
significantly to the difference in nonheme iron absorption. Since it is not obvious what 
this individual difference may be, future studies are recommended to further investigate 
these interperson differences. The second study also shows that the percentage iron 
bioavailability from the US diet is 15 %, which is less than the value of 18 % used in 
developing the DRIs for iron. This finding is very important in reassessing the current 
DRIs for iron. It is also relevant in other aspects of iron nutrition such as program 
planning and dietary guidance. In the third study, we found that regular consumption of 
high phytate food may dampen the inhibitory effect of phytate on iron absorption. This 
study has implications on the biofortification of high phytate staples in developing 
countries. Since individuals in these countries consume high phytate foods habitually, 
high phytate staples can still be biofortified with iron to improve iron nutritional status in 
these countries. A major gap in this research is identifying the mechanism underlying this 
observation. While hepcidin was considered a possible mediator of the effect of long term 
phytate consumption, our data did not support this hypothesis, neither did any of the iron 
status biomarkers explain the mechanism. Future studies are therefore recommended to 
investigate the mechanism of adaptation in iron absorption. 
